S&W Seed (SANW) 10-Q 26 Nov 24 2025 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Sep. 30, 2024	Nov. 20, 2024
Cover [Abstract]
Entity Registrant Name	S&W SEED CO
Entity Central Index Key	0001477246
Document Type	10-Q
Document Period End Date	Sep. 30, 2024
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity File Number	001-34719
Entity Tax Identification Number	27-1275784
Entity Address, Address Line One	2101 Ken Pratt Blvd
Entity Address, Address Line Two	Suite 201
Entity Address, City or Town	Longmont
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80501
City Area Code	720
Local Phone Number	506-9191
Entity Common Stock, Shares Outstanding		2,284,470
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2025
Trading Symbol	SANW
Title of 12(b) Security	Common Stock, par value $0.001 per share
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	NV
Document Quarterly Report	true
Document Transition Report	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2024	Jun. 30, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 480,359	$ 286,508
Accounts receivable, net	16,588,371	14,636,722
Receivable from unconsolidated subsidiary	367,349	0
Inventories, net	26,549,387	22,628,343
Prepaid expenses and other current assets	2,616,306	3,431,226
Current assets of discontinued operations	0	22,391,691
TOTAL CURRENT ASSETS	46,601,772	63,374,490
Property, plant and equipment, net	5,980,625	6,127,198
Intellectual property, net	19,919,389	20,265,618
Other intangibles, net	3,099,003	3,206,720
Right of use assets - operating leases	890,086	1,113,833
Equity method investments	18,847,331	19,694,209
Other assets	1,272,948	1,364,532
Non-current assets of discontinued operations	0	5,578,941
TOTAL ASSETS	96,611,154	120,725,541
CURRENT LIABILITIES
Accounts payable	9,396,043	3,255,928
Payable to to unconsolidated subsidiary	16,214,514	0
Deferred revenue	2,056,703	832,283
Accrued expenses and other current liabilities	5,814,941	3,770,773
Bank guarantee	5,000,000	0
Current portion of working capital lines of credit, net	16,114,500	16,174,537
Current portion of long-term debt, net	284,239	315,304
Current liabilities of discontinued operations	0	44,893,499
TOTAL CURRENT LIABILITIES	54,880,940	69,242,324
Long-term debt, net, less current portion	4,652,369	4,721,849
Other non-current liabilities	659,996	800,620
Non-current liabilities of discontinued operations	0	929,623
TOTAL LIABILITIES	60,193,305	75,694,416
MEZZANINE EQUITY
Preferred stock, $0.001 par value; 3,323 shares authorized; 1,695 issued and outstanding at September 30, 2024 and June 30, 2024	5,896,657	5,768,765
STOCKHOLDERS' EQUITY
Common stock, $0.001 par value; 75,000,000 shares authorized; 2,284,096 issued and 2,282,780 outstanding at September 30, 2024; 2,282,574 issued and 2,281,258 outstanding at June 30, 2024	43,398	43,369
Treasury stock, at cost, 1,316 shares at September 30, 2024 and June 30, 2024	(134,196)	(134,196)
Additional paid-in capital	169,048,535	168,807,072
Accumulated deficit	(138,448,097)	(122,090,479)
Accumulated other comprehensive loss	(30,156)	(7,405,114)
Non-controlling interests	41,708	41,708
TOTAL STOCKHOLDERS' EQUITY	30,521,192	39,262,360
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	96,611,154	120,725,541
MEZZANINE EQUITY
MEZZANINE EQUITY
Preferred stock, $0.001 par value; 3,323 shares authorized; 1,695 issued and outstanding at September 30, 2024 and June 30, 2024	$ 5,896,657	$ 5,768,765

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Sep. 30, 2024	Jun. 30, 2024
STOCKHOLDERS' EQUITY
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	2,284,096	2,282,574
Common stock, shares outstanding	2,282,780	2,281,258
Treasury stock, shares	1,316	1,316
MEZZANINE EQUITY
SERIES B CONVERTIBLE PREFERRED STOCK
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	3,323	3,323
Preferred stock, shares issued	1,695	1,695
Preferred stock, shares outstanding	1,695	1,695

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenue	$ 8,309,476	$ 10,757,347
Cost of revenue (excluding depreciation and amortization shown separately below)	6,973,108	8,032,197
Gross profit	1,336,368	2,725,150
Operating expenses
Selling, general and administrative expenses	4,002,211	4,153,561
Research and development expenses	741,820	778,889
Depreciation and amortization	814,453	806,835
Loss (gain) on disposal of property, plant and equipment	11,462	(22,091)
Total operating expenses	5,569,946	5,717,194
Loss from operations	(4,233,578)	(2,992,044)
Other expense (income)
Foreign currency loss	7,926	570
Interest expense - amortization of debt discount	361,138	356,567
Interest expense, net	761,879	948,728
Other (income) expenses	22,686	(37,560)
Net loss from continuing operations before income taxes	(5,387,207)	(4,260,349)
Provision for (benefit from) income taxes	1,142	(12,292)
Net loss from continuing operations before equity in net earnings of affiliates	(5,388,349)	(4,248,057)
Equity in loss of equity method investee, net of tax	846,878	776,973
Net loss from continuing operations	(6,235,227)	(5,025,030)
Net loss from discontinued operations	(9,994,499)	(931,887)
Net loss	(16,229,726)	(5,956,917)
Loss attributable to non-controlling interests		(7,288)
Net loss attributable to S&W Seed Company	(16,229,726)	(5,949,629)
Calculation of net loss per share
Net Income (Loss)	(16,229,726)	(5,949,629)
Dividends accrued for participating securities and accretion	(127,892)	(120,045)
Net loss attributable to common shareholders	$ (16,357,618)	$ (6,069,674)
Net loss per share from continuing operations, basic	$ (2.73)	$ (2.22)
Net loss per share from continuing operations diluted	(2.73)	(2.22)
Net loss per share from discontinued operations, basic	(4.38)	(0.41)
Net loss per share from discontinued operations diluted	(4.38)	(0.41)
Basic	(7.11)	(2.63)
Diluted	(7.11)	(2.63)
Net loss attributable to common shareholders per common share, basic	(7.17)	(2.68)
Net loss attributable to common shareholders per common share, diluted	$ (7.17)	$ (2.68)
Weighted average number of common shares outstanding:
Basic	2,282,780	2,263,643
Diluted	2,282,780	2,263,643

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (16,229,726)	$ (5,956,917)
Foreign currency translation adjustment, net of income taxes	4,061	(160,979)
Deconsolidation of subsidiary impact on currency translation adjustment, net of income taxes	7,370,897	0
Comprehensive loss	(8,854,768)	(6,117,896)
Comprehensive loss attributable to non-controlling interests	0	(7,288)
Comprehensive loss attributable to S&W Seed Company	$ (8,854,768)	$ (6,110,608)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)	Total	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interests	Accumulated Other Comprehensive Loss
Mezzanine Equity Beginning Balance, amount at Jun. 30, 2023		$ 5,274,148
Mezzanine Equity Beginning Balance, shares at Jun. 30, 2023		1,695
Beginning Balance, amount at Jun. 30, 2023	$ 68,823,433		$ 43,004	$ (134,196)	$ 167,768,104	$ (91,932,808)	$ 67,120	$ (6,987,791)
Beginning Balance, shares at Jun. 30, 2023			2,263,369	(1,316)
Stock-based compensation, amount	411,820				411,820
Mezzanine equity series B detachable warrant	25,838	$ 25,838
Series B detachable warrant	(25,838)					(25,838)
Mezzanine equity accrued dividends on Series B convertible preferred stock	94,207	94,207
Accrued dividends on Series B convertible preferred stock	(94,207)					(94,207)
Net issuance to settle RSUs, amount	(15,176)		$ 44		(15,220)
Net issuance to settle RSUs, shares			2,313
Cash paid related to stock issuance costs	(153,230)				(153,230)
Other comprehensive income (loss)	(160,979)							(160,979)
Net loss	(5,956,917)					(5,949,629)	(7,288)
Ending Balance, amount at Sep. 30, 2023	62,828,906		$ 43,048	$ (134,196)	168,011,474	(98,002,482)	59,832	(7,148,770)
Ending Balance, shares at Sep. 30, 2023			2,265,682	(1,316)
Mezzanine Equity Ending Balance, amount at Sep. 30, 2023		$ 5,394,193
Mezzanine Equity Ending Balance, shares at Sep. 30, 2023		1,695
Mezzanine Equity Beginning Balance, amount at Jun. 30, 2024	5,768,765	$ 5,768,765
Mezzanine Equity Beginning Balance, shares at Jun. 30, 2024		1,695
Beginning Balance, amount at Jun. 30, 2024	39,262,360		$ 43,369	$ (134,196)	168,807,072	(122,090,479)	41,708	(7,405,114)
Beginning Balance, shares at Jun. 30, 2024			2,282,574	(1,316)
Stock-based compensation, amount	$ 243,908				243,908
Issuance of common stock for cash upon exercise of stock options, shares	0
Mezzanine equity series B detachable warrant	$ 25,838	$ 25,838
Series B detachable warrant	(25,838)					(25,838)
Mezzanine equity accrued dividends on Series B convertible preferred stock	102,054	102,054
Accrued dividends on Series B convertible preferred stock	(102,054)					(102,054)
Net issuance to settle RSUs, amount	(2,416)		$ 29		(2,445)
Net issuance to settle RSUs, shares			1,522
Deconsolidation of subsidiary	7,370,897							7,370,897
Other comprehensive income (loss)	4,061							4,061
Net loss	(16,229,726)					(16,229,726)
Ending Balance, amount at Sep. 30, 2024	30,521,192		$ 43,398	$ (134,196)	$ 169,048,535	$ (138,448,097)	$ 41,708	$ (30,156)
Ending Balance, shares at Sep. 30, 2024			2,284,096	(1,316)
Mezzanine Equity Ending Balance, amount at Sep. 30, 2024	$ 5,896,657	$ 5,896,657
Mezzanine Equity Ending Balance, shares at Sep. 30, 2024		1,695

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (16,229,726)	$ (5,956,917)
Net loss from discontinued operations	(9,994,499)	(931,887)
Net loss from continuing operations	(6,235,227)	(5,025,030)
Adjustments to reconcile net loss from operating activities to net loss cash used in operating activities:
Stock-based compensation	243,908	402,641
Provision for credit losses	0	165,342
Inventory write-down	298,127	350,000
Depreciation and amortization	814,453	806,835
Loss (gain) on disposal of property, plant and equipment	11,462	(22,091)
Equity in loss of equity method investees, net of tax	846,878	776,973
Foreign currency transactions	7,926	570
Amortization of debt discount	361,138	356,567
Accretion of note receivable	0	(63,738)
Changes in:
Accounts receivable	(1,947,797)	(1,596,260)
Receivable from unconsolidated subsidiary	113,383	0
Inventories	(4,219,171)	(455,529)
Prepaid expenses and other current assets	814,968	(503,941)
Other non-current assets	1,089	35,834
Accounts payable	6,140,115	5,208,316
Payable to unconsolidated subsidiary	250,495	0
Deferred revenue	1,224,420	(157,440)
Accrued expenses and other current liabilities	2,055,445	1,761,480
Other non-current liabilities	3,050	21,985
Net cash provided by operating activities from continuing operations	784,662	2,062,514
Net cash used in operating activities from discontinuing operations	(1,434,917)	(1,267,836)
Net cash (used in) provided by operating activities	(650,255)	794,678
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment	(138,041)	(116,346)
Proceeds from disposal of property, plant and equipment	25,700	74,657
Net cash used in investing activities from continuing operations	(112,341)	(41,689)
Net cash provided by (used in) investing activities from discontinuing operations	25,079	(105,089)
Net cash used in investing activities	(87,262)	(146,778)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings and repayments on lines of credit, net	(344,155)	(4,306,362)
Borrowings of long-term debt	0	9,087
Repayments of long-term debt	(81,847)	(2,420)
Payments of debt issuance costs	(50,169)	(41,322)
Net proceeds from sale of common stock	0	(153,230)
Taxes paid related to net share settlements of stock-based compensation awards	(2,416)	(15,176)
Net cash used in financing activities from continuing operations	(478,587)	(4,509,423)
Net cash provided by financing activities from discontinued operations	1,409,838	1,409,452
Net cash provided by (used) in financing activities	931,251	(3,099,971)
EFFECT OF EXCHANGE RATE CHANGES ON CASH	117	40,700
NET INCREASE (DECREASE) IN CASH & CASH EQUIVALENTS	193,851	(2,411,371)
CASH AND CASH EQUIVALENTS, beginning of the period	286,508	3,398,793
CASH AND CASH EQUIVALENTS, end of period	480,359	987,422
Cash paid during the period for:
Interest	831,003	1,360,904
Income taxes	$ 25	$ 22,225

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (16,229,726)	$ (5,949,629)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

General

General	3 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL	NOTE 1 - GENERAL S&W Seed Company, or the Company, is a global multi-crop, middle-market agricultural company that is principally engaged in breeding, growing, processing and selling agricultural seeds. The Company operates seed cleaning and processing facilities. The Company’s seed products are primarily grown under contract by farmers. The Company is currently focused on growing sales of their proprietary and traited products specifically through the expansion of Double Team TM for forage and grain sorghum products and new trait introductions, including the second generation of Double Team and Prussic Acid Free TM , or PF, improving profit margins through pricing and operational efficiencies, and developing the camelina market via a partnership formed in fiscal 2023. Voluntary Administration Process Involving S&W Australia On July 24, 2024, the Company's wholly-owned subsidiary S&W Seed Company Australia Pty Ltd., or S&W Australia, adopted a voluntary plan of administration based on its determination that S&W Australia is likely to become “insolvent” within the meaning of section 436A(1) of Australia’s Corporations Act 2001. In Australia, voluntary administration is a process whereby an insolvent company is placed in the hands of one or more independent administrators whose role is to investigate the company’s affairs, to report to creditors and to recommend to creditors whether the company should enter into a deed of company arrangement, liquidation, or be returned to its board of directors. A voluntary administration involves an investigation of available options to provide a better return to creditors and, if possible, to save the business. A number of factors combined to lead S&W Australia to conclude that the voluntary plan of administration was necessary and advisable, including the lack of viable strategic alternatives, Saudi Arabia’s recent discontinuation of import permits for alfalfa seed, and the increased risk that S&W Australia would be unable to meet its obligations under its financing agreement with National Australia Bank Limited, or NAB. As a result of the voluntary administration process, effective July 24, 2024, the Company no longer controls S&W Australia for accounting purposes, and on October 11, 2024, creditors of S&W Australia approved a proposed Deed of Company Arrangement, pursuant to which, among other things, the outstanding shares of S&W Australia would be transferred to a third party. The Company's expectation was that S&W Australia would no longer be its subsidiary, or owned or controlled by the Company in any manner, at the conclusion of the voluntary administration process and therefore all of the related business conducted through S&W Australia would cease to be included within the scope of its business. Since the Company no longer controls S&W Australia for accounting purposes, S&W Australia was deconsolidated from the Company's financial statements as of July 24, 2024. The Company will not regain control of S&W Australia, as detailed further in Note 15 - Subsequent Events. S&W Australia’s entry into voluntary administration constituted an event of default and automatic acceleration of S&W Australia’s obligations under the Amended and Restated Finance Agreement with NAB, effective November 17, 2023, or the NAB Finance Agreement. However, such acceleration is stayed while S&W Australia is under voluntary administration. The NAB Finance Agreement was guaranteed by the Company, up to a maximum of AUD $ 15.0 million (USD $ 10.4 million as of September 30, 2024), or the Parent Guarantee. The Company’s obligations under the Parent Guarantee were not subject to a stay in connection with S&W Australia’s voluntary administration. On November 22, 2024, NAB released the Company from all liability under the Parent Guarantee, as detailed further in Note 15 - Subsequent Events. S&W Australia’s entry into voluntary administration also constituted an event of default under the Company’s Amended CIBC Loan Agreement with CIBC Bank USA, or CIBC, as a result of a cross-default provision in the Amended CIBC Loan Agreement that is triggered by the event of default under the NAB Finance Agreement. On August 5, 2024, the Company received a waiver for the Event of Default from CIBC. The waiver stipulates that the occurrence of any of the following shall constitute an immediate event of default under the Amended CIBC Loan Agreement, without notice or demand of any kind: • Any notice of default and/or demand for payment is issued by NAB to the Company under the Parent Guarantee; • The institution of any legal proceedings by NAB against the Company; and • NAB takes any other judicial or non-judicial action under the Parent Guarantee or otherwise against the Company in connection with the Parent Guarantee. In the event that any of the above events occur, the Company must provide immediate written notice to CIBC. The Company is also required to provide written weekly updates, in form and substance satisfactory to CIBC, addressing S&W Australia’s insolvency proceeding and/or any actions or communications from NAB with respect to S&W Australia’s insolvency proceeding or the Parent Guarantee as well as any actions or progress in furtherance of a sale of S&W Australia or all or any material part of its business. None of the events of default under the August 5, 2024 CIBC waiver have occurred as of the date of this filing and the Company has also met the weekly reporting requirements as outlined in the waiver. Discontinued Operations As discussed in Note 3 - Discontinued Operations, effective July 24, 2024, the Company no longer controls S&W Australia for accounting purposes and as such, deconsolidated this subsidiary. This met the criteria to be accounted for as a discontinued operation as required by Accounting Standards Codification, or ASC, 205-20, Discontinued Operations. Accordingly, the financial results of S&W Australia are reported as discontinued operations in the accompanying unaudited Condensed Consolidated Statements of Operations for all periods presented. All amounts and disclosure included in the accompanying notes to the Condensed Consolidated Financial Statements reflect only the Company's continuing operations unless otherwise noted. Reverse Stock Split A reverse stock split of all issued and outstanding shares of the Company's common stock, at a ratio of 1-for-19 , or the Reverse Stock Split, was implemented at 5:00 p.m. Eastern Time on October 17, 2024. The Company has retroactively adjusted all share amounts and per share data herein to give effect to the Reverse Stock Split. Refer to Note 15 - Subsequent Events for additional information on the Reverse Stock Split. Basis of Presentation The accompanying Condensed Consolidated Financial Statements are unaudited and, in the Company’s opinion, include all adjustments, consisting of normal recurring adjustments and accruals, necessary for a fair statement of the Company’s condensed consolidated balance sheets, statements of operations, comprehensive loss, cash flows and mezzanine equity and stockholders’ equity for the periods presented. Operating results for the periods presented are not necessarily indicative of the results to be expected for the full year ending June 30, 2025. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted in accordance with the rules and regulations of the SEC. These Condensed Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Annual Report on Form 10-K for the fiscal year ended June 30, 2024, as filed with the SEC on November 1, 2024. The Company has reportable segments that correspond with its operating model, management structure, and internal reporting reviewed by its Chief Operating Decision Maker, who is the Chief Executive Officer. The Company's Chief Operating Decision Maker allocates resources and assesses performance based on these segments. Effective with the loss of control of S&W Australia on July 24, 2024, this was reduced to two operating segments, each its own reportable segment, Americas and International. The Company previously had one additional operating and reportable segment, AUSDOM, which related to the Australian domestic business and was included in discontinued operations for the three months ended September 30, 2024 and is presented as such for all periods in this report. Refer to Note 10 - Business Segments for additional information regarding the Company's reportable segments. Certain prior period information has been reclassified to conform to the current period presentation. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates are adjusted to reflect actual experience when necessary. Significant estimates and assumptions affect many items in the financial statements. In the Annual Report on Form 10-K for the year ended June 30, 2024 filed with this SEC on November 1, 2024, this included the recoverability of long-lived assets and inventory valuation. Significant estimates and assumptions are also used to establish the fair value and useful lives of depreciable tangible and certain intangible assets as well as valuing stock-based compensation. Actual results may differ from those estimates and assumptions, and such results may affect income, financial position or cash flows. The Company believes the estimates and assumptions underlying the accompanying Condensed Consolidated Financial Statements are reasonable and supportable based on the information available at the time the financial statements were prepared. However, certain adverse geopolitical and macroeconomic events, such as the ongoing conflict between Ukraine and Russia and related sanctions, the armed conflict in Sudan, the conflict in the Middle East, the import ban on alfalfa seed in Saudi Arabia, and uncertain market conditions, including higher inflation and supply chain disruptions, have, among other things, negatively impacted the global economy, created significant volatility and disruption of financial markets, and significantly increased economic and demand uncertainty. These factors make many of the estimates and assumptions reflected in these Condensed Consolidated Financial Statements inherently less certain. Therefore, actual results may ultimately differ from those estimates to a greater degree than historically.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Liquidity and Going Concern The Company is not profitable and has recorded negative cash flows from operating activities for the last several years. For the three months ended September 30, 2024, the Company reported a net loss from continuing operations of $ 6.2 million and a net loss from discontinued operations of $ 10.0 million, which included a $ 9.8 million loss from the deconsolidation of S&W Australia. The Company has an accumulated deficit of $ 138.4 million as of September 30, 2024. As of September 30, 2024, the Company had cash on hand of $ 0.5 million and negative working capital of $ 8.3 million. The Company had no unused availability from its working capital facility with CIBC as of September 30, 2024 (see Note 9 - Debt for further discussion). The Company’s Amended and Restated Loan and Security Agreement with CIBC, or the Amended CIBC Loan Agreement, is classified as current on the Company's Condensed Consolidated Balance Sheets given that the debt is due within 12 months of the September 30, 2024. The Amended CIBC Loan Agreement matures on November 30, 2024 , given that we delivered to CIBC by November 8, 2024, an amended letter of credit issued by JPMorgan Chase Bank, N.A. for the account of MFP Partners L.P., extending the letter of credit to December 31, 2024. The Amended CIBC Loan Agreement contains various financial covenants. Adverse geopolitical and macroeconomic events and other factors affecting the Company’s results of operations have increased the risk of the Company’s inability to comply with these covenants, which could result in acceleration of its repayment obligations and foreclosure on its pledged assets. Effective September 16, 2024, and since then, the revolving loan outstanding under the Amended CIBC Loan Agreement (as amended on July 3, 2024) has exceeded the total revolving loan commitment thereunder, which constitutes an event of default. On September 18, 2024, the Company received a reservation of rights letter from CIBC asserting the existence of such event of default, increasing the interest rate applicable to the loans by 2 % per annum (which is the default rate under the Amended CIBC Loan Agreement), and reserving CIBC’s right to immediately exercise any of CIBC’s other rights or remedies under the Amended CIBC Loan Agreement as it deems appropriate. As of the date of this filing, this remains in default and CIBC has not accelerated the indebtedness under the Amended CIBC Loan Agreement. S&W Australia’s entry into voluntary administration constituted an event of default under the Company’s Amended CIBC Loan Agreement, as a result of a cross-default provision in the Amended CIBC Loan Agreement that is triggered by the event of default under the NAB Finance Agreement. On August 5, 2024, the Company received a waiver for the event of default from CIBC, which contained certain stipulations outside of the Company's control and detailed further in Note 1 - General. The voluntary administration process resulted in the transfer of S&W Australia's assets, as noted in Note 15 - Subsequent Events. While we obtained waivers for certain defaults and covenants in the past, there can be no assurance we will be successful in meeting our covenants, avoiding future defaults, or securing future waivers and/or amendments from our lenders. If we are unsuccessful in doing so, as currently is the case with CIBC, we may need to reduce the scope of our operations, repay amounts owing to our lenders, finance our cash needs through a combination of equity and debt financings, enter into collaborations, strategic alliances and licensing arrangements, delay payments to our growers, sell certain assets or divest certain operations. Further, if the Company cannot renew or find other financing options when its debt facility with CIBC expires on November 30, 2024, it may need to reduce the scope of its operations, repay amounts owed to its lenders and/or sell certain assets. Additionally, if the Company is not able to find a buyer for S&W Australia, it may be required to pay the Parent Guarantee, which, in turn, could cause the Company to reduce the scope of its operations, repay amounts owed to its lenders, and/or sell certain assets. These operating and liquidity factors raise substantial doubt regarding the Company’s ability to continue as a going concern. The Company’s Condensed Consolidated Financial Statements do not include any adjustments that might result from the outcome of this uncertainty. Cost of Revenue The Company records purchasing and receiving costs, inspection costs and warehousing costs in Cost of revenue. When the Company is required to pay for outward freight and/or the costs incurred to deliver products to its customers, the costs are included in Cost of revenue. Cash and Cash Equivalents For financial statement presentation purposes, the Company considers time deposits, certificates of deposit and all highly liquid investments with original maturities of three month s or less to be cash and cash equivalents. At times, cash and cash equivalents balances exceed amounts insured by the Federal Deposit Insurance Corporation. Cash balances located outside of the United States may not be insured and totaled $ 0.0 million on September 30, 2024 and June 30, 2024. Cash balances residing in the United States exceeding the Federal Deposit Insurance Corporation limit of $ 250,000 totaled $ 0.2 million and $ 0.0 million on September 30, 2024 and June 30, 2024, respectively. International Operations The Company translates its foreign operations’ assets and liabilities denominated in foreign currencies into U.S. dollars at the current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of accumulated other comprehensive loss. Gains or losses from foreign currency transactions are included in the Condensed Consolidated Statements of Operations. For the three months ended September 30, 2024 and 2023, the Co mpany recognized the following foreign currency transaction gains in Cost of revenue and losses in Foreign currency loss within Other expense (income) in the Condensed Consolidated Statements of Operations: Three Months Ended September 30, 2024 2023 Cost of revenue $ ( 453 ) $ ( 233 ) Foreign currency loss 7,926 570 Total $ 7,473 $ 337 Accounts Receivable The Company provides an allowance for credit losses equal to the estimated uncollectible amounts. Prior to July 1, 2023, that estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer’s trade accounts receivable. Effective July 1, 2023, in determining the Company's reserve for credit losses, receivables are assigned an expected loss based on historical information adjusted for forward-looking economic factors. The allowance for credit losses was $ 0.5 million on September 30, 2024 and June 30, 2024. Inventories Inventories consist of seed and packaging materials. Inventories are stated at the lower of cost or net realizable value, and an inventory reserve permanently reduces the cost basis of inventory. Inventories are valued as follows: Actual cost is used to value raw materials such as packaging materials, as well as goods in process. Costs for substantially all finished goods, which include the cost of carryover crops from the previous year, are valued at actual cost. Actual cost for finished goods includes plant conditioning and packaging costs, direct labor and raw materials and manufacturing overhead costs based on normal capacity. The Company records abnormal amounts of idle facility expense, freight, handling costs and wasted material (spoilage) as current period charges and allocates fixed production overhead to the costs of finished goods based on the normal capacity of the production facilities. Inventory is periodically reviewed to determine if it is marketable, obsolete or impaired. Inventory that is determined to be obsolete or impaired is written off to expense at the time the impairment is identified. Inventory quality is a function of germination percentage. Our experience has shown that our alfalfa seed quality tends to be stable under proper storage conditions; therefore, we do not view inventory obsolescence for alfalfa seed as a material concern. Hybrid crops (sorghum and sunflower) seed quality may be affected by warehouse storage pests such as insects and rodents. The Company maintains a strict pest control program to mitigate risk and maximize hybrid seed quality. Components of inventory are as follows: As of September 30, 2024 As of June 30, 2024 Raw materials and supplies $ 1,614,377 $ 1,324,087 Work in progress 8,388,736 2,305,572 Finished goods 16,546,274 18,998,684 Inventories, net $ 26,549,387 $ 22,628,343 Property, Plant and Equipment Property, plant and equipment is depreciated using the straight-line method over the estimated useful life of the asset - periods of 5 to 35 years for buildings, 3 to 20 years for machinery and equipment, 7 to 10 years for leasehold improvements, and 2 to 5 years for vehicles. Intangible Assets Intangible assets acquired in business acquisitions are reported at their initial fair value less accumulated amortization. Intangible assets are amortized using the straight-line method over the estimated useful life of the asset. Periods of 10 to 30 years for technology/IP/germplasm, 5 to 20 years for customer relationships and trade names and 10 to 20 for other intangible assets. The weighted average estimated useful lives are 25 years for technology/IP/germplasm, 19 years for customer relationships, 16 years for trade names, and 18 years for other intangible assets as of September 30, 2024. Investments The Company has one partnership resulting in a 34 % ownership interest in Vision Bioenergy. Following the initial recording of this investment, the Company assesses and records its share of equity earnings from the investment on a quarterly basis, resulting in the investment carrying value increasing or decreasing depending on whether a gain or loss is recorded. Research and Development Costs The Company is engaged in ongoing research and development, or R&D, of proprietary seed varieties. All R&D costs must be charged to expense as incurred. Accordingly, internal R&D costs are expensed as incurred. Third-party R&D costs are expensed when the contracted work has been performed or as milestone results have been achieved. The costs associated with equipment or facilities acquired or constructed for R&D activities that have alternative future uses are capitalized and depreciated on a straight-line basis over the estimated useful life of the asset. Income Taxes Deferred tax assets and liabilities are determined based on differences between the financial statement and tax basis of assets and liabilities, as well as a consideration of net operating loss and credit carry forwards, using enacted tax rates in effect for the period in which the differences are expected to impact taxable income. A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company’s effective tax rate for the three months ended September 30, 2024 and 2023 ha s been affected by the valuation allowance on the Company’s deferred tax assets. Net Loss Per Common Share Data The Company computes earnings per share using the two-class method. The two-class method requires an earnings allocation formula that determines earnings per share for common shareholders and participating security holders according to dividends declared and participating rights in undistributed earnings. The Company's Series B Preferred Stock and related warrant, or Series B Warrant (see Note 14 - Series B Redeemable Convertible Preferred Stock of the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC), are participating securities because holders of such shares have non-forfeitable dividend rights and participate in any undistributed earnings with common stock. Under the two-class method, total dividends provided to the holders of participating securities and undistributed earnings allocated to participating securities, are subtracted from net income attributable to the Company in determining net loss attributable to common shareholders in the two-class earnings per share, or EPS, calculation. Accretion to the redemption value for the Series B Preferred Stock is also treated as a deemed dividend and subtracted from net income attributable to shareholders. There were no undistributed earnings to allocate to the participating securities in the three months ended September 30, 2024 and 2023. The calculation of net loss per common share is shown in the table below: Three Months Ended September 30, 2024 2023 Numerator: Net loss from continuing operations $ ( 6,235,227 ) $ ( 5,025,030 ) Net loss from discontinued operations ( 9,994,499 ) ( 931,887 ) Net loss ( 16,229,726 ) ( 5,956,917 ) Loss attributable to non-controlling interests — ( 7,288 ) Net loss attributable to S&W Seed Company ( 16,229,726 ) ( 5,949,629 ) Dividends accrued for participating securities ( 102,054 ) ( 94,207 ) Accretion of Series B Preferred Stock redemption value ( 25,838 ) ( 25,838 ) Numerator for net loss per common share - basic and diluted $ ( 16,357,618 ) $ ( 6,069,674 ) Denominator: Denominator for basic and diluted net loss per share - weighted average shares 2,282,780 2,263,643 Net loss per common share - basic and diluted $ ( 7.17 ) $ ( 2.68 ) Anti-dilutive shares, which have been excluded from the computation of diluted loss per share, included 279,670 employee stock options, 67,960 restricted stock units, 89,211 shares issuable upon conversion of the Series B Convertible Preferred Stock, warrants to purchase 138,600 shares of common stock related to the MFP Loan Agreement (as defined below), and 29,440 warrants issued with the Company's Series B Convertible Preferred Stock. The terms and conditions of these securities are more fully described in Note 13 - Equity-Based Compensation and Note 14 - Series B Redeemable Convertible Preferred Stock of the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC. For the period ended September 30, 2024 and 2023 , all potentially dilutive shares were anti-dilutive and excluded from the calculation of diluted loss per share because net losses were recognized. Concentrations One customer accounted for 20 % and another customer accounted for an additional 16 % of revenue for the three months ended September 30, 2024. One customer accounted for 22 % and another customer accounted for 18 % of the Company's revenue for the three months ended September 30, 2023. One customer accounted for 15 % and another customer accounted for an additional 10 % of the Company's accounts receivable as of September 30, 2024 and one customer accounted for 17 % and another customer accounted for an additional 16 % of the Company’s accounts receivable as of June 30, 2024. The Company sells a substantial portion of its products to international customers (see Note 5 - Revenue Recognition). Sales to international markets represented 65 % and 72 % of revenue during the three months ended September 30, 2024 and 2023, respectiv ely. The net book value of fixed assets located outside the United States w as 0 % of total fixed assets on September 30, 2024 and June 30, 2023 , respectively, from continuing operations . Fair Value of Financial Instruments The Company discloses assets and liabilities that are recognized and measured at fair value, presented in a three-tier fair value hierarchy, as follows: • Level 1. Observable inputs such as quoted prices in active markets; • Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and • Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The carrying value of cash and cash equivalents, accounts payable, short-term and all long-term borrowings, as reflected in the condensed consolidated balance sheets, approximate fair value because of the short-term maturity of these instruments or interest rates commensurate with market rates. There have been no changes in operations and/or credit characteristics since the date of issuance that could impact the relationship between interest rate and market rates. The Company’s obligations under the Parent Guarantee were not subject to stay in connection with S&W Australia’s voluntary administration and follows the terms of the facilities S&W Australia has with NAB, with the primary borrowing base line expiring on March 31, 2025. As the Company lost control and deconsolidated S&W Australia as a result from the voluntary administration process, the Company must recognize a liability for the fair value of the Parent Guarantee per ASC 460, Guarantees. In order for this any payments to occur, NAB must first make a claim under the Parent Guarantee, which has not occurred as of September 30, 2024. The Company assessed the fair value of the Parent Guarantee as of July 24, 2024 and elected to record the guarantee at fair value at each reporting date, with any changes in fair value being recorded as a gain or loss in the Company's Condensed Consolidated Statements of Operations. The Company obtained an independent valuation, assigning probabilities under various scenarios and applying estimated recovery and discount rates, which resulted in a $ 5.0 million liability being recorded for the Parent Guarantee under Bank guarantee on the Company's Condensed Consolidated Balance Sheets as of July 24, 2024 and September 30, 2024. The Company determined the fair value of the Parent Guarantee based on a scenario analysis, which included a discount rate ranging between 25.4 % and 35.4 % as of July 24, 2024 and 25.5 % and 35.5 % as of September 30, 2024, and a weighted average recovery rate of 57.8 % as of July 24, 2024 and September 30, 2024. As discussed further in Note - 15, Subsequent Events, the Company was released of the Parent Guarantee from NAB on November 22, 2024. In conjunction with the Vision Bioenergy partnership transaction, S&W received a one-time option, or Purchase Option, exercisable at any time on or before the fifth anniversary of the closing of the partnership transaction, to repurchase a 6 % membership interest from Shell. The option repurchase prices range between approximately $ 7.1 and $ 12.0 million, depending on the date on which such purchase is completed. The Purchase Option was valued at $ 0.7 million using a lattice option valuation model. The valuation model incorporated significant, unobservable inputs including a discounted cash flow model based on management projections of future Vision Bioenergy results and an estimate of the current per share value of Vision Bioenergy shares. In the model, the estimate of the current per share value was discounted to account for lack of control and marketability, which were considered to be part of the unit of account given the restrictions of the limited liability com pany agreement that governs the ownership rights of the members. Other unobservable inputs included the risk-free rates and the estimated future stock volatility based on the historical stock price volatilities of other market participants. A full fair value analysis will be performed at each fiscal year-end or when there is an indication that there may be an impairment to the valuation. Management will estimate and adjust the balance for interim periods. A full fair value analysis will be performed whenever there is a potential indicator of impairment to the valuation. No indicators have been identified for the three months ended September 30, 2024 to suggest any material change in the fair value of the purchase option. Quantitative information about Level 3 fair value measurement is as follows: Fair Value as of September 30, 2024 Valuation Technique Unobservable Input Range Purchase Option $ 695,000 Option Model Risk-free rate 3.8 % - 4.9 % Stock price volatility 60 % - 65 % Lack of control premium 13 % Lack of marketability premium 30 % Assets and liabilities that are recognized and measured at fair value on a recurring basis are categorized as follows as of September 30, 2024 and June 30, 2024: Fair Value Measurements as of September 30, 2024: Level 1 Level 2 Level 3 Bank guarantee — — $ 5,000,000 Vision Bioenergy interest purchase option — — 695,000 Total $ — $ — $ 5,695,000 Fair Value Measurements as of June 30, 2024: Level 1 Level 2 Level 3 Vision Bioenergy interest purchase option — — $ 695,000 Total $ — $ — $ 695,000 Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures, or ASU 2023-07, which requires an enhanced disclosure of segments on an annual and interim basis, including the title of the chief operating decision maker, significant segment expenses, and the composition of other segment items for each segment's reported profit. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and adoption of ASU 2023-07 should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of this standard. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures, or ASU 2023-09, expanding the disclosures requirement for income taxes primarily by requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted, and adoption of ASU 2023-09 can be applied prospectively or retrospectively. The Company is currently evaluating the impact of this standard. We have evaluated all other issued and unadopted Accounting Standards Updates and believe the adoption of these standards will not have a material impact on our condensed consolidated statements of operations, comprehensive income, balance sheets, or cash flows.

Discontinued Operations

Discontinued Operations	3 Months Ended
	Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	NOTE 3 - DISCONTINUED OPERATIONS On July 24, 2024, S&W Australia adopted a voluntary plan of administration based on its determination that S&W Australia is likely to become “insolvent” within the meaning of section 436A(1) of Australia’s Corporations Act 2001. As a result of the voluntary plan of administration, the Company no longer controls S&W Australia for accounting purposes and was deconsolidated as of July 24, 2024. The Company does not expect to regain control of S&W Australia at the conclusion of the voluntary administration process. This represents a strategic shift given that S&W Australia represents a material component of the Company's operations, including as one of the Company's reportable segments, AUSDOM, and a material part of another reportable segment, International, for the year ended June 30, 2024. This met the criteria to be accounted for as a discontinued operation as of July 24, 2024 under ASC 205-20, Discontinued Operations. S&W Australia's entry into voluntary administration constituted a reconsideration event, requiring the Company to reassess S&W Australia's status as a Variable Interest Entity, or VIE. The Company deconsolidated the entity because it no longer has the power to direct the activities that most significantly impact the S&W Australia's economic performance. As the Company lost control of but retained its ownership shares in S&W Australia effective July 24, 2024, it met the criteria to be classified as a VIE under ASC 810, Consolidation, with the investment not having any value. The Company has been providing limited services and support to S&W Australia as they have been going through the voluntary administration process, which did not result in a material amount being less than $ 0.1 million for the three months ended September 30, 2024. Accordingly, the operating results of the discontinued operations for the three months ended September 30, 2024 and 2023 are presented in the Condensed Consolidated Statements of Operations within Net loss from discontinued operations. For the three months ended September 30, 2024, this includes S&W Australia activity from July 1, 2024 through July 24, 2024, the date the Company no longer controlled and deconsolidated S&W Australia. A reconciliation to Net loss from discontinued operations is as follows: Three Months Ended September 30, 2024 2023 Revenue $ 842,545 $ 5,675,119 Cost of revenue (excluding depreciation and amortization shown separately below) 572,862 3,388,955 Gross profit 269,683 2,286,164 Operating expenses Selling, general and administrative expenses 276,096 1,633,018 Research and development expenses 50,713 307,623 Depreciation and amortization 47,660 262,187 Loss (gain) on disposal of property, plant and equipment 25,696 ( 10,864 ) Total operating expenses 400,165 2,191,964 (Loss) income from operations ( 130,482 ) 94,200 Other (income) expense Loss on deconsolidation of subsidiary 9,828,253 — Foreign currency (gain) loss ( 120,877 ) 371,619 Interest expense - amortization of debt discount 6,799 99,007 Interest expense, net 149,842 457,039 Net loss from discontinued operations before income taxes ( 9,994,499 ) ( 833,465 ) Provision for income taxes from discontinued operations — 13,499 Net loss from discontinued operations before equity in net earnings of affiliates ( 9,994,499 ) ( 846,964 ) Equity in loss of equity method investee, net of tax, from discontinued operations — 84,923 Net loss from discontinued operations $ ( 9,994,499 ) $ ( 931,887 ) The following table presents assets and liabilities of discontinued operations as of June 30, 2024: ASSETS As of June 30, 2024 CURRENT ASSETS Cash and cash equivalents $ 7,506 Accounts receivable, net 6,228,502 Inventories, net 15,478,760 Prepaid expenses and other current assets 676,923 CURRENT ASSETS OF DISCONTINUED OPERATIONS 22,391,691 NON-CURRENT ASSETS Property, plant and equipment, net 3,540,075 Intangibles, net 576,669 Right of use assets - operating leases 1,134,985 Other assets 327,212 NON-CURRENT ASSETS OF DISCONTINUED OPERATIONS 5,578,941 TOTAL ASSETS OF DISCONTINUED OPERATIONS $ 27,970,632 LIABILITIES CURRENT LIABILITIES Accounts payable $ 10,235,898 Deferred revenue 40,456 Accrued expenses and other current liabilities 3,123,721 Current portion of working capital lines of credit, net 27,549,620 Current portion of long-term debt, net 3,943,804 CURRENT LIABILITIES OF DISCONTINUED OPERATIONS 44,893,499 Long-term debt, net, less current portion 151,387 Other non-current liabilities 778,236 NON-CURRENT LIABILITIES OF DISCONTINUED OPERATIONS 929,623 TOTAL LIABILITIES OF DISCONTINUED OPERATIONS $ 45,823,122 The Company recorded a loss on the deconsolidation of S&W Australia of $ 9.8 million on July 24, 2024, which is included within Net loss from discontinued operations in the Condensed Consolidated Statements of Operations for the three months ended September 30, 2024. In accordance with ASC 810, Consolidation, the recorded loss was measured as the excess liabilities over assets in S&W Australia's ledger as of July 24, 2024, less all currency translation adjustments related to S&W Australia, as all unrealized gains and losses must be realized upon deconsolidation. The Company also recognized the fair value of the Parent Guarantee as of September 30, 2024 as a liability, with the offset going to Loss on deconsolidation of subsidiary. Below is a reconciliation of the loss on deconsolidation of S&W Australia: As of July 24, 2024 Realization of currency translation adjustments from accumulated other comprehensive loss $ 7,289,430 Recognition of bank guarantee (see Note 1) 5,000,000 S&W Australia total assets 43,168,611 S&W Australia total liabilities ( 45,629,788 ) Loss on deconsolidation of subsidiary $ 9,828,253 A reconciliation of S&W Australia total assets and total liabilities as of July 24, 2024 is as follows: As of July 24, 2024 CURRENT ASSETS Cash and cash equivalents $ 85,876 Accounts receivable, net 6,311,994 Receivable from unconsolidated subsidiary 15,549,595 Inventories, net 15,274,546 Prepaid expenses and other current assets 666,509 TOTAL CURRENT ASSETS 37,888,520 Property, plant and equipment, net 3,322,273 Other intangibles, net 554,850 Right of use assets - operating leases 1,093,946 Other assets 309,022 TOTAL ASSETS $ 43,168,611 CURRENT LIABILITIES Accounts payable $ 9,150,910 Payable to unconsolidated subsidiary 520,213 Deferred revenue 33,047 Accrued expenses and other current liabilities 2,947,985 Current portion of working capital lines of credit, net 28,263,338 Current portion of long-term debt, net 3,828,839 TOTAL CURRENT LIABILITIES 44,744,332 Long-term debt, net, less current portion 127,288 Other non-current liabilities 758,168 TOTAL LIABILITIES $ 45,629,788

Leases

Leases	3 Months Ended
	Sep. 30, 2024
Lessee Disclosure [Abstract]
LEASES	NOTE 4 - LEASES The Company leases office and laboratory space, research plots and equipment used in connection with its operations under various operating and finance leases. The components of lease assets and liabilities as of September 30, 2024 and June 30, 2024 are as follows: Leases Balance Sheet Classification: As of September 30, 2024 As of June 30, 2024 Assets: Right of use assets - finance leases $ 1,050,072 $ 1,086,667 Accumulated amortization - finance leases ( 553,172 ) ( 499,275 ) Right of use assets - finance leases, net Other assets 496,900 587,392 Right of use assets - operating leases Right of use assets - operating leases 890,086 1,113,833 Total lease assets $ 1,386,986 $ 1,701,225 Liabilities: Current lease liabilities - finance leases Current portion of long-term debt, net $ 295,671 $ 314,980 Current lease liabilities - operating leases Accrued expenses and other current liabilities 327,048 380,492 Long-term portion of lease liabilities - Long-term debt, net, less current portion 223,454 303,395 Long-term portion of lease liabilities - Other non-current liabilities 659,996 800,620 Total lease liabilities $ 1,506,169 $ 1,799,487 The components of lease cost are as follows: Three Months Ended September 30, Lease cost: Income Statement Classification: 2024 2023 Operating lease cost Cost of revenue $ 60,766 $ 60,944 Operating lease cost Selling, general and administrative expenses 33,026 36,542 Operating lease cost Research and development expenses 21,310 37,135 Finance lease cost Depreciation and amortization 57,386 67,497 Finance lease cost Interest expense, net 14,163 10,036 Total lease costs $ 186,651 $ 212,154 Maturities of lease liabilities as of September 30, 2024, are as follows: Fiscal Year Operating Leases Finance Leases Remainder of 2025 $ 311,147 $ 247,175 2026 354,960 277,359 2027 241,622 44,615 2028 183,599 — 2029 56,967 — Total lease payments 1,148,295 569,149 Less: Interest ( 161,251 ) ( 50,024 ) Present value of lease liabilities $ 987,044 $ 519,125 The following are the weighted average assumptions used for lease term and discount rate and supplemental cash flow information related to leases as of September 30, 2024: As of September 30, 2024 Operating lease remaining lease term 3.3 years Operating lease discount rate 8.53 % Finance lease remaining lease term 1.6 years Finance lease discount rate 9.48 % Cash paid for operating leases $ 114,089 Cash paid for finance leases $ 105,709

Revenue Recognition

Revenue Recognition	3 Months Ended
	Sep. 30, 2024
Revenues [Abstract]
REVENUE RECOGNITION	NOTE 5 - REVENUE RECOGNITION The Company derives its revenue primarily from the sale of seed products to seed distributors. From time to time, the Company utilizes excess capacity to provide conditioning, treating and packaging services to other seed producers. The Company also derives service revenue from its partnership with Vision Bioenergy Oilseeds LLC, or Vision Bioenergy, by providing administrative services under a service level agreement. Revenue from seed product sales is recognized at the point in time at which control of the product is transferred to the customer. Generally, this occurs upon shipment of the product. Pricing for such transactions is negotiated and determined at the time the contracts are signed. We have elected the practical expedient that allows us to account for shipping and handling activities as a fulfillment cost, and we accrue those costs when the related revenue is recognized. The Company has certain contracts with customers that offer a limited right of return on certain branded products through the end of the current sales year (September through August). The products must be in an unopened and undamaged state and must be resalable in the sole opinion of the Company to qualify for a refund. The Company uses a historical returns percentage to estimate the refund liability and records a reduction of revenue in the period in which revenue is recognized. ADAMA Collaboration Agreement The Company has an amended collaboration agreement, or Amended Collaboration Agreement, with Makhteshim Agan of North America, Inc., or ADAMA, for the development and commercialization of the Double Team Sorghum Weed Control System, or DT, which is comprised of ADAMA’s ACCase herbicide used in concert with the Company’s ACCase tolerant ATS Sorghum product, Double Team Sorghum Cropping Solution. Although the DT product is designed to be used as a system, the Company sells only the Double Team sorghum seed portion of the system and recognizes the revenue consistent with its sales of other seed products. Under the Amended Collaboration Agreement, the Company will only label and promote ATS Sorghum products with ADAMA herbicides, while ADAMA will not sell ACCase herbicides for use on competing ATS Sorghum products. Further, all DT related trademarks are jointly owned by the Company and ADAMA, and each company grants the other a royalty-free license to use these DT related trademarks. The costs of breeding, trait introgression, variety evaluation, performing quality assurance activities and obtaining seed registrations will be borne by the Company while the cost of development, performance evaluation, performing quality assurance activities and obtaining chemical registrations will be borne by ADAMA. The parties have agreed to share all other costs, except those associated with marketing communications. Double Team sorghum seed sales were ($ 0.1 ) million and $ 0.5 million for the three months ended September 30, 2024 and 2023, respectively. Payment Terms and Related Balance Sheet Accounts Accounts receivable represent amounts that are payable to the Company by its customers subject only to the passage of time. Payment terms on invoices are generally 30 to 180 days for export customers and end of sales season (October 31st) for branded products sold within the United States. As the period between the transfer of goods and/or services to the customer and receipt of payment is less than one year , the Company does not separately account for a financing component in its contracts with customers. The Company had $ 0.2 million in unbilled receivables as of September 30 , 2024 and June 30, 2024, which related to its service level agreement with Vision Bioenergy, as the Company bills Vision Bioenergy on a quarterly basis. Losses on accounts receivable and unbilled receivables are re cognized using a forward-looking approach. The Company considers current and expected future economic conditions as well as the performance of borrowers to determine the allowance for credit losses. During the three months ended September 30, 2024 and 2023, the Company recognized bad debt expense of $ 0.0 million and $ 0.2 million, respectively, associated with impaired accounts receivable. Deferred revenue represents payments received from customers in advance of completion of the Company's performance obligation. During the three months ended September 30, 2024 and 2023, the Company recognized $ 0.2 million and $ 0.4 million of revenue, respectively, that was included in the deferred balance as of June 30, 2024 and 2023, respectively. Disaggregation of Revenue The Company disaggregates revenue by type of contract and by destination country. The following table shows revenue from external sources by type of contract: Three Months Ended September 30, 2024 2023 Seed sales: Alfalfa $ 6,708,003 $ 7,086,370 Sorghum 1,432,857 3,509,966 Other 11,224 ( 46,649 ) Services 157,392 207,660 Total revenue $ 8,309,476 $ 10,757,347 The following tables show revenue and percentage of revenue from external sou rces by destination country: Three Months Ended September 30, 2024 2023 United States $ 2,934,716 35 % $ 3,014,244 28 % Libya 1,295,550 16 % 1,072,800 10 % Mexico 1,052,781 13 % 1,562,814 9 % Sudan 807,530 10 % 1,267,933 12 % South Africa 533,125 6 % 1,195,553 11 % Egypt 496,360 6 % — 0 % Uganda 299,640 4 % 40,000 0 % Morocco 287,994 3 % — 0 % Qatar 148,574 2 % 58,500 1 % Argentina 89,289 1 % 35,400 0 % Saudi Arabia — 0 % 2,208,738 26 % Other 363,917 4 % 301,365 3 % Total revenue $ 8,309,476 100 % $ 10,757,347 100 %

Intangible Assets

Intangible Assets	3 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 6 – INTANGIBLE ASSETS Intangible assets consist of the following: Balance at June 30, 2024 Balance at September 30, 2024 Gross Carrying Amount Accumulated Amortization Net Amortization Gross Carrying Amount Accumulated Amortization Net Intellectual property $ 33,325,737 $ ( 13,060,119 ) $ 20,265,618 $ ( 346,229 ) $ 33,325,737 $ ( 13,406,348 ) $ 19,919,389 Trade name 1,831,928 ( 1,178,972 ) 652,956 ( 21,120 ) 1,831,928 ( 1,200,092 ) 631,836 Customer relationships 1,596,653 ( 1,019,623 ) 577,030 ( 22,602 ) 1,596,653 ( 1,042,225 ) 554,428 GI customer list 121,786 ( 93,131 ) 28,655 ( 1,791 ) 121,786 ( 94,922 ) 26,864 Supply agreement 1,512,667 ( 888,692 ) 623,975 ( 18,908 ) 1,512,667 ( 907,600 ) 605,067 Grower relationships 2,343,977 ( 1,223,208 ) 1,120,769 ( 26,352 ) 2,343,977 ( 1,249,560 ) 1,094,417 Internal use software 677,776 ( 474,441 ) 203,335 ( 16,944 ) 677,776 ( 491,385 ) 186,391 $ 41,410,524 $ ( 17,938,186 ) $ 23,472,338 $ ( 453,946 ) $ 41,410,524 $ ( 18,392,132 ) $ 23,018,392 Amortization expense totaled $ 0.5 million and $ 0.5 million f or the three months ended September 30, 2024 and 2023, respectively. Estimated aggregate remaining amortization is as follows: Remainder of 2025 2026 2027 2028 2029 Thereafter Amortization expense $ 1,343,921 $ 1,714,386 $ 1,663,502 $ 1,606,211 $ 1,586,728 $ 15,103,644

Property, Plant and Equipment

Property, Plant and Equipment	3 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT	NOTE 7 - PROPERTY, PLANT AND EQUIPMENT Components of property, plant and equipment were as follows: As of September 30, 2024 As of June 30, 2024 Land and improvements $ 586,849 $ 586,849 Buildings and improvements 2,365,835 2,371,565 Machinery and equipment 8,785,882 8,621,280 Vehicles 663,778 648,836 Leasehold improvements 473,307 552,810 Construction in progress 3,341 28,453 Total property, plant and equipment 12,878,992 12,809,793 Less: accumulated depreciation ( 6,898,367 ) ( 6,682,595 ) Property, plant and equipment, net $ 5,980,625 $ 6,127,198 Depreciation expense tot aled $ 0.3 million and $ 0.3 million f or the three months ended September 30, 2024 and 2023 , respectively.

Investments

Investments	3 Months Ended
	Sep. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]
Investments	NOte 8 - investments Shell Partnership The terms and conditions of the Contribution and Membership Interest Purchase Agreement, or Purchase Agreement, with Shell relating to the February 6, 2023 partnership for the development and production of sustainable biofuel feedstocks through Vision Bioenergy are presented in Note 7 - Investments to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024. No new activity occurred during the three months ended September 30, 2024 . Activity in the period consisted of the recording of the Company's 34 % share of Vision Bioenergy's loss for the period, which is recorded to Equity in loss of equity method investees, net of tax in the Condensed Consolidated Statements of Operations. The summarized unaudited balance sheet presented below reflects the financial information of Vision Bioenergy as of September 30, 2024 and June 30, 2024: As of September 30, 2024 (Unaudited) As of June 30, 2024 (Unaudited) Cash $ 4,523,734 $ 6,327,459 Other current assets 6,689,246 3,138,627 Fixed assets 17,818,133 17,866,091 Intangible assets 18,976,035 19,624,187 Goodwill 11,564,157 11,564,157 Other assets 155,214 235,613 TOTAL ASSETS $ 59,726,519 $ 58,756,134 Current liabilities $ 4,957,388 $ 1,485,283 Long-term liabilities 77,845 133,070 Equity 54,691,286 57,137,781 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 59,726,519 $ 58,756,134 The summarized unaudited income statement presented below reflects the financial information of Vision Bioenergy for the three months ended September 30, 2024 and 2023: Three Months Ended September 30, 2024 (Unaudited) 2023 (Unaudited) Revenue $ 307,772 $ 110,900 Gross loss ( 486,271 ) ( 549,607 ) Loss from operations ( 2,497,925 ) ( 2,432,762 ) Net loss ( 2,446,495 ) ( 2,362,135 ) The following summarizes the carrying amount of the Company's equity method investments reflected in the Condensed Consolidated Balance Sheets: As of September 30, 2024 As of June 30, 2024 Carrying Amount Economic Interest Carrying Amount Economic Interest Vision Bioenergy $ 18,847,331 34 % $ 19,694,209 34 % Total equity method investments $ 18,847,331 $ 19,694,209 For the three month s ended September 30, 2024, the following activity occurred in the Company's equity method investments: Vision Bioenergy Carrying amount at June 30, 2024 $ 19,694,209 Equity in loss of equity method investment ( 846,878 ) Carrying amount at September 30, 2024 $ 18,847,331

Debt

Debt	3 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
DEBT	NOTE 9 - DEBT Total debt outstanding is presented on the Company's Condensed Consolidated Balance Sheets as follows: As of September 30, 2024 As of June 30, 2024 Current portion of working capital lines of credit CIBC $ 16,169,873 $ 16,279,194 Debt issuance costs ( 55,373 ) ( 104,657 ) Total working capital lines of credit, net $ 16,114,500 $ 16,174,537 Current portion of long-term debt Finance leases $ 295,671 $ 314,980 Vehicle loans - Ford Credit 95,096 106,852 Debt issuance costs ( 106,528 ) ( 106,528 ) Total current portion, net $ 284,239 $ 315,304 Long-term debt, less current portion Finance leases $ 223,454 $ 303,395 Vehicle loans - Ford Credit 205,674 222,063 Secured real estate note - AgAmerica 4,300,000 4,300,000 Debt issuance costs ( 76,759 ) ( 103,609 ) Total long-term portion, net $ 4,652,369 $ 4,721,849 Total debt, net $ 4,936,608 $ 5,037,153 CIBC Loan Agreement On December 26, 2019 , the Company entered into the CIBC Loan Agreement with CIBC, which originally provided for a $ 35.0 million credit facility, or the CIBC Credit Facility. As described in Note 8 - Debt to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ende d June 30, 2024, the CIBC Loan Agreement was subsequently amended on several occasions, including on March 22, 2023, when the Company entered into the Amended CIBC Loan Agreement. During the three months ended September 30, 2024, the Amended CIBC Loan Agreement was amended as follows: • On July 3, 2024, the Company entered into a Third Amendment to the Amended and Restated Loan and Security Agreement, or the Third Amendment, with CIBC, which amended the Amended CIBC Loan Agreement, by and among the Company, as borrower, and CIBC, as administrative agent and sole lead arranger. The Third Amendment, effective as of July 1, 2024, among other things: o subject to the satisfaction of certain post-closing covenants, extended the maturity date from August 31, 2024 to October 31, 2024 , or the Maturity Date; o modified the maximum loan commitment under the Amended CIBC Loan Agreement to (i) $ 20.0 million from July 1, 2024 through July 31, 2024, (ii) $ 18.5 million from August 1, 2024 through September 1, 2024, (iii) $ 17.5 million from September 2, 2024 through September 15, 2024, (iv) $ 15.0 million from September 16, 2024 through October 9, 2024, and (v) $ 13.0 million from October 10, 2024 through the Maturity Date; o modified the eligible inventory sublimit under the Amended CIBC Loan Agreement from $ 5.0 million from July 1, 2024 through August 31, 2024 to (i) $ 8.5 million from July 1, 2024 through July 14, 2024, (ii) $ 7.5 million from July 15, 2024 through August 14, 2024, (iii) $ 7.0 million from August 15, 2024 through September 15, 2024, (iv) $ 6.5 million from September 16, 2024 through September 29, 2024, and (v) $ 5.0 million from September 30, 2024 through the Maturity Date; o added certain post-closing covenants which, should the Company not comply with the amended terms, shall constitute an immediate event of default under the Amended CIBC Loan Agreement; o added a fee of $ 15,000 payable by the Company to CIBC on the date of the Third Amendment; o added a fee of $ 10,000 payable by the Company to CIBC monthly beginning July 1, 2024, and payable only if the eligible inventory sublimit is greater than $ 5.0 million; and o added a fee of $ 25,000 payable by the Company to CIBC on October 1, 2024, and payable only if the Company does not repay the obligations under the Amended CIBC Loan Agreement in full by September 30, 2024. Except as modified by the Third Amendment, all terms and conditions of the Amended CIBC Loan Agreement remain in full force and effect as of September 30, 2024. On October 31, 2024, the Maturity Date was extended to November 30, 2024 , detailed further in Note 15 - Subsequent Events. The proceeds of advances under the Amended CIBC Credit Facility may be used to finance the Company’s ongoing working capital requirements and other general corporate purposes. Availability of funds under the Amended CIBC Credit Facility is subject to a borrowing base equal to (a) up to 85 % of eligible domestic accounts receivable, plus (b) up to 90 % of eligible foreign accounts receivable, plus (c) up to the lesser of (i) 65 % of eligible inventory and (ii) 85 % of the appraised net orderly liquidation value of eligible inventory , in each case subject to an eligible inventory sublimit, in each case ((a), (b) and (c)), as more fully set forth in the Amended CIBC Loan Agreement and subject to lender reserves that C IBC may establish from time to time in its sole discretion, determined in good faith. Advances under the Amended CIBC Credit Facility bear interest at a rate per annum equal to a reference rate equal to CIBC’s prime rate at any time (or, if greater, the federal funds rate at such time plus 0.5 %) plus an applicable margin of 2.5 %. The interest rate for the Amended CIBC Credit Facility was 10.50 % as of September 30, 2024. The Company’s obligations under the Amended CIBC Loan Agreement are secured by a first priority security interest in substantially all of the Company’s assets (subject to certai n exceptions), including intellectual property. The Amended CIBC Loan Agreement contains certain customary representations and warranties, events of default, and affirmative and negative covenants, including limitations with respect to debt, liens, fundamental changes, asset sales, restricted payments, investments and transactions with affiliates, subject to certain exceptions. Amounts due under the Amended CIBC Loan Agreement may be accelerated upon an “event of default,” as defined in the Amended CIBC Loan Agreement, such as failure to pay amounts owed thereunder when due, breach of a covenant, material inaccuracy of a representation, or occurrence of bankruptcy or insolvency, subject in some cases to cure periods. Additionally, upon the occurrence and during the continuance of an event of default, CIBC may elect to increase the existing interest rate on all of the Company’s outstanding obligations by 2.0 % per annum. As of September 16, 2024, and since then, the revolving loan outstanding under the Amended CIBC Loan Agreement (as amended by the Third Amendment) has exceeded the total revolving loan commitment thereunder, which constitutes an event of default under the Amended CIBC Loan Agreement. On September 18, 2024, the Company received a reservation of rights letter from CIBC asserting the existence of such event of default, increasing the interest rate applicable to the loans by 2.0 % per annum (which is the default rate under the Amended CIBC Loan Agreement), and reserving CIBC’s right to immediately exercise any of CIBC’s other rights or remedies under the Amended CIBC Loan Agreement as it deems appropriate. As of the date of this filing, CIBC has not accelerated the indebtedness under the Amended CIBC Loan Agreement. AgAmerica Note As described in Note 8 - Debt to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024, the Company entered into a term loan agreement, or the AgAmerica Loan Agreement, with AgAmerica on June 20, 2023 pursuant to which AgAmerica issued a term loan of $ 4.3 million to the Company and, as security therefor, the Company granted to AgAmerica a mortgage on approximately 31 acres of land located in Lubbock and Moore Counties, Texas, and certain personal property thereon. No changes to this agreement have occurred during the three months ended September 30, 2024. Per the agreement, interest will accrue at a rate per annum equal to 4.85 % plus the Term SOFR Rate , defined as the forward-looking term rate based on the secured overnight financing rate, or SOFR, computed based on the actual number of days elapsed divided by a 360-day year. The annual interest rate as of September 30, 2024 was 9.81 %. Interest payments are due quarterly in arrears, commencing on June 20, 2023, and on the last day of each quarter thereafter, unless otherwise accelerated in accordance with the terms of the AgAmerica Loan Agreement. The AgAmerica Loan Agreement contains certain customary representations and warranties, events of default, and affirmative and negative covenants, including (among others) limitations with respect to liens, fundamental changes, asset sales and formation and acquisition of subsidiaries, subject to certain exceptions. Upon the occurrence of an event of default, and subject to certain cure periods, AgAmerica may declare all outstanding obligations immediately due and payable and take such other actions as set forth in the AgAmerica Loan Agreement, as applicable, provided that in the event of bankruptcy, all such amounts shall automatically become due and payable. Due to the delayed filing of the Annual Report on Form 10-K for the year ended June 30, 2024, the Company was not in compliance with the reporting requirements per the AgAmerica Loan Agreement; however, a waiver was received from AgAmerica for such non-compliance, executed on November 1, 2024. The Company is in compliance with all reporting requirements as of the date of this filing. MFP Loan Agreement On September 22, 2022, the Company’s largest stockholder, MFP Partners, L.P., or MFP, provided a letter of credit issued by JPMorgan Chase Bank, N.A. for the account of MFP, with an initial face amount of $ 9.0 million, or the MFP Letter of Credit, for the benefit of CIBC, as additional collateral to support the Company’s obligations under the CIBC Loan Agreement. Concurrently, on September 22, 2022, the Company entered into a Subordinate Loan and Security Agreement, or the MFP Loan Agreement, with MFP, pursuant to which any draw CIBC may make on the MFP Letter of Credit will be deemed to be a term loan advance made by MFP to the Company. The MFP Loan Agreement initially provided for up to $ 9.0 million of term loan advances. In connection with the Company’s entry into the Amended CIBC Loan Agreement, the MFP Letter of Credit was amended to increase the maximum amount of term loan advances to $ 13.0 million and extend the maturity date to September 30, 2024 . On July 16, 2024, the Company entered into a Fourth Amendment to Subordinate Loan and Security Agreement with MFP, or the MFP Fourth Amendment, amending the MFP Loan Agreement with MFP, to (i) extend the maturity date of the letter of credit to November 30, 2024 and (ii) extend the maturity date of the MFP Loan Agreement to May 31, 2025 . On October 31, 2024, the MFP Letter of Credit was further extended to December 31, 2024 . See Note 15 - Subsequent Events for further details. Except as modified by these amendments, all terms and conditions of the MFP Loan Agreement remain in full force and effect. Pursuant to the amended MFP Loan Agreement, the Company accrues a cash fee to be paid to MFP equal to 4.25 % per annum on all amounts remaining undrawn under the MFP Letter of Credit. In the event any term advances are deemed made under the MFP Loan Agreement, such advances will bear interest at a rate per annum equal to term SOFR (with a floor of 1.25 %) plus 9.25 %, 50 % of which will be payable in cash on the last day of each fiscal quarter and 50 % of which will accrue as payment in kind interest payable on the maturity date, unless, with respect to any quarterly payment date, the Company elects to pay such interest in cash. As of September 30, 2024, no amounts were outstanding. The MFP Loan Agreement, as amended, includes customary affirmative and negative covenants and events of default and is secured by substantially all of the Company’s assets and is subordinated to the CIBC Loan Agreement. Upon the occurrence and during the continuance of an event of default, MFP may declare all outstanding obligations under the MFP Loan Agreement immediately due and payable and take such other actions as set forth in the MFP Loan Agreement. Maturities of Long-Term Debt The annual maturities of long-term debt, excluding finance lease liabilities, are as follows: Fiscal Year Amount Remainder of 2025 $ 95,096 2026 4,395,096 2027 95,096 2028 15,482 Total $ 4,600,770

Business Segments

Business Segments	3 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
BUSINESS SEGMENTS	NOTE 10 - BUSINESS SEGMENTS Segment Reporting Prior to the voluntary administration of S&W Australia, the Company had three operating and reportable segments that corresponded with its operating model, management structure, and internal reporting reviewed by its Chief Operating Decision Maker, who is the Company's President and Chief Executive Officer. Effective with the loss of control of S&W Australia on July 24, 2024, this was reduced to two operating and reportable segments. The Company's Chief Operating Decision Maker currently allocates resources and assesses performance based on these two segments, with a key performance metric utilized being gross profit. The Company's two operating segments, each its own reportable segment, are Americas and International. Note, as a result of the voluntary administration of S&W Australia, the Company's Chief Operating Decision Maker no longer allocates resources and assesses performance for the AUSDOM segment and for the International segment related to S&W Australia. Americas : Consists of operations in the United States that results in sales across North and South America. Revenue in the Americas segment is largely made up of sorghum and alfalfa products. International : Consists of operations in the United States that results in sales to countries outside of North and South America. Revenue in the International segment is largely alfalfa products in addition to some sorghum and sunflower products. A large concentration of these sales went to the Middle East and North Africa region. As presented in the table below, Other consists of intercompany activity with S&W Australia. This has historically been eliminated; however, with the deconsolidation of this subsidiary, the activity is no longer eliminated on a go forward basis as of July 24, 2024. Below is a summary of business activity by segment that is reviewed by the Company's Chief Operating Decision Maker for the three months ended September 30, 2024 and 2023: Three Months Ended September 30, 2024 2023 Revenue Americas $ 4,132,935 $ 4,854,052 International 4,089,006 5,903,295 Other 87,535 — Revenue 8,309,476 10,757,347 Gross profit (excluding depreciation and amortization) Americas 728,263 952,325 International 797,183 1,773,768 Other ( 189,078 ) ( 943 ) Gross profit (excluding depreciation and amortization) $ 1,336,368 $ 2,725,150 The Company does not allocate Other (income) expense, Equity in loss of equity method investees, net of tax, or Assets by segment as these are not provided to its Chief Operating Decision Maker.

Equity

Equity	3 Months Ended
	Sep. 30, 2024
Equity [Abstract]
EQUITY	NOTE 11 – EQUITY MFP Warrants On September 22, 2022, the Company entered into a Subordinate Loan and Security Agreement, or the MFP Loan Agreement, with MFP, pursuant to which any draw CIBC may make on the MFP Letter of Credit will be deemed to be a term loan advance made by MFP to the Company (see Note 9 - Debt). Pursuant to the terms and conditions of the MFP Loan Agreement and subsequent amendments on October 28, 2022, December 22, 2022 and March 22, 2023, warrants to purchase a total of 138,600 shares of the Company’s common stock were issued to MFP in fiscal 2023. All warrants will expire five years from the date of issuance and have exercise prices ranging from $ 30.40 - $ 40.85 per share. The stated purchase prices of all of the MFP Warrants are subject to adjustment in connection with any stock dividends and splits, distributions with respect to common stock and certain fundamental transactions as described in the MFP Warrant. The MFP Warrants were valued using the Black-Scholes-Merton model as of the respective issue dates and recorded as financial commitment assets within Prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets. The MFP Warrants financial commitment assets are amortized on a straight-line basis over the period from their initial issue dates through the end of the related MFP Letter of Credit commitment periods. During the three months ended September 30, 2024 and 2023, $ 0.2 million and $ 0.2 million, respectively, was amortized as interest expense. MFP is the Company’s largest shareholder. One of the Company’s directors, Alexander C. Matina, was Portfolio Manager of MFP Investors LLC, the general partner of MFP, until December 31, 2023, at which point he transitioned to an advisor role for MFP Investors LLC. Mr. Matina continues to serve on the Company's board of directors, or the Board.

Equity-Based Compensation

Equity-Based Compensation	3 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
EQUITY-BASED COMPENSATION	NOTE 12 - EQUITY-BASED COMPENSATION Stock Options The Company utilizes a Black-Scholes-Merton option pricing model, which includes assumptions regarding the risk-free interest rate, dividend yield, life of the award, and the volatility of the Company's common stock to estimate the fair value of employee options grants. During the three months ended September 30, 2024 and 2023, the Company did no t grant options to its directors, certain members of the executive management team or other employees. A summary of stock option activity for the three months ended September 30, 2024 is presented below: Number of Weighted - Weighted- Aggregate Outstanding at June 30, 2024 279,670 $ 39.14 6.8 $ — Granted — — — — Exercised — — — — Canceled/forfeited/expired — — — — Outstanding at September 30, 2024 279,670 $ 39.14 6.5 $ — Options vested and exercisable at September 30, 2024 241,434 $ 42.67 6.2 $ — Options vested and expected to vest at September 30, 2024 279,422 $ 39.20 6.5 $ — On September 30, 2024 , the Company had $ 209,592 of unrecognized stock compensation expense, net of estimated forfeitures, related to the options under the S&W Seed Company 2019 Equity Incentive Plan, or 2019 Plan, which will be recognized over the weighted average remaining service period of 1.7 years. The Company settles employee st ock option exercises with newly issued shares of common stock. Restricted Stock Units During the three months ended September 30, 2024 and 2023, the Company issued 5,246 and 1,361 restricted stock units, respectively, to its directors, certain members of the executive management team, other employees, and non-employee service providers. The restricted stock units have varying vesting periods ranging from immediate vesting to quarterly or annual installments over one to three years . The fair value of the awards granted during the three months ended September 30, 2024 and 2023 totaled $ 35,375 and $ 29,373 , respectively, and was based on the closing stock price on the date of grants. A summary of activity related to non-vested restricted stock units is presented below: Number of Weighted-Average Weighted-Average Nonvested restricted units outstanding at June 30, 2024 64,595 $ 11.40 1.2 Granted 5,246 11.34 0.3 Vested ( 1,881 ) 17.04 — Nonvested restricted units outstanding at September 30, 2024 67,960 10.83 1.14 On September 30, 2024, th e Company had $ 278,144 of unrecognized stock compensation expense related to the restricted stock units, which will be recognized over the weighted average remaining service period of 1.1 years. Stock-based Compensation Expense Stock-based compensation expense recorded for grants of stock options, restricted stock grants and restricted stock units for the three months ended September 30, 2024 and 2023 totaled $ 243,908 and $ 411,820 , respectively. On September 30, 2024, there w ere 8,676 share s available under the 2019 Plan for future grants and awards.

Series B Redeemable Convertible

Series B Redeemable Convertible Preferred Stock	3 Months Ended
	Sep. 30, 2024
Temporary Equity Disclosure [Abstract]
Series B Redeemable Convertible Preferred Stock	NOTE 13 – SERIES B REDEEMABLE CONVERTIBLE PREFERRED STOCK The terms and conditions of the Company’s Series B Redeemable Convertible Preferred Stock and accompanying warrant are presented in Note 14 - Series B Redeemable Convertible Preferred Stock to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024. No issuances or conversions of Series B Redeemable Convertible Preferred Stock occurred during the three months ended September 30, 2024. Activity in the period consisted of accrual of dividends and accretion of the discount on the warrants. The following summarizes changes to the Series B Convertible Preferred Stock: Balance at June 30, 2024 $ 5,768,765 Dividends accrued 102,054 Accretion of discount for warrants 25,838 Balance at September 30, 2024 $ 5,896,657

Non-Cash Activities for Stateme

Non-Cash Activities for Statements of Cash Flows	3 Months Ended
	Sep. 30, 2024
Supplemental Cash Flow Elements [Abstract]
NON-CASH ACTIVITIES FOR STATEMENTS OF CASH FLOWS	NO TE 14 - NON-CASH ACTIVITIES FOR STATEMENTS OF CASH FLOWS The below table represents supplemental information to the Company’s condensed consolidated statements of cash flows for non-cash activities during the three months ended September 30, 2024 and 2023, respectively, for continuing operations, unless otherwise specified: Three Months Ended September 30, 2024 2023 Non-cash investing activities: ROU assets financed by lease liabilities and lease modifications and reassessments $ ( 106,838 ) $ 487,611 Non-cash financing activities: Dividends accrued for participating securities 102,054 94,207 Accretion of discount for Series B preferred stock warrants 25,838 25,838

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 15 - SUBSEQUENT EVENTS CIBC Fourth Amendment On October 31, 2024, the Company entered into a Fourth Amendment to the Amended and Restated Loan and Security Agreement with CIBC, or the Fourth Amendment, which amended the Amended CIBC Loan Agreement by and among the Company, as borrower, and CIBC, as administrative agent and sole lead arranger. The Fourth Amendment, effective as of October 31, 2024, among other things: • extended the maturity date from October 31, 2024 to November 30, 2024 , contingent upon the Company's delivery to CIBC of an amended letter of credit issued by JPMorgan Chase Bank, N.A. for the account of MFP, and for the benefit of CIBC, that expires on December 31, 2024, which was delivered on November 8, 2024; and • provided for a fee of $ 25,000 payable by the Company to CIBC on the date of the Fourth Amendment. Except as modified by the Fourth Amendment, all terms and conditions of the Amended CIBC Loan Agreement remain in full force and effect. MFP Fifth Amendment On October 31, 2024, the Company entered into a Fifth Amendment to Subordinate Loan and Security Agreement with MFP, or the MFP Fifth Amendment, further amending the MFP Loan Agreement with MFP, to extend the maturity date of the letter of credit to December 31, 2024 . Except as modified by the MFP Fifth Amendment, all terms and conditions of the MFP Loan Agreement remain in full force and effect. Reverse Stock Split At the Company's special meeting of stockholders held on September 26, 2024, or the Special Meeting, the Company's stockholders approved, pursuant to Nevada Revised Statutes, or NRS, 78.2055, a reverse stock split of the Company's common stock at a ratio in the range of 1-for-5 to 1-for-20 , with such ratio to be determined in the discretion of the Board and with such reverse stock split to be effected at such time and date as determined by the Board in its sole discretion (but in no event later than January 31, 2025). Following the Special Meeting, on October 4, 2024, the Board unanimously approved, pursuant to NRS 78.2055, a reverse stock split of all issued and outstanding shares of our common stock, at a ratio of 1-for-19 , or the Reverse Stock Split. The Reverse Stock Split was implemented at 5:00 p.m. Eastern Time on October 17, 2024, or the Effective Time. The terms of the Reverse Stock Split are such that every 19 shares of the Company’s issued and outstanding common stock were automatically combined into one issued and outstanding share of common stock, without any change in par value per share. As a result of the Reverse Stock Split, proportionate adjustments were made to the per share exercise price and/or the number of shares issuable upon the exercise or vesting of all then outstanding stock options, restricted stock units and warrants, which resulted in a proportional decrease in the number of shares of the Company's common stock reserved for issuance upon exercise or vesting of such stock options, restricted stock units and warrants, and, in the case of stock options and warrants, a proportional increase in the exercise price of all such stock options and warrants. In addition, the number of shares reserved for issuance under the Company's equity compensation plans immediately prior to the Effective Time was reduced proportionately. No fractional shares were issued in connection with the Reverse Stock Split. Stockholders of record were issued one whole share of common stock in exchange for any fractional interest that such stockholder would have otherwise received as a result of the Reverse Stock Split. The Reverse Stock Split affected all stockholders of record proportionately and did not affect any stockholder’s percentage ownership of the Company’s common stock, except to the extent that the Reverse Stock Split resulted in any stockholder owning an additional share. The Company's common stock began trading on a split-adjusted basis commencing upon market opening on The Nasdaq Capital Market on October 18, 2024. S&W Australia As previously reported, S&W Australia adopted a voluntary plan of administration on July 24, 2024, and on October 11, 2024, creditors of S&W Australia approved a proposed Deed of Company Arrangement, or DOCA, pursuant to which, among other things, the outstanding shares of S&W Australia would be transferred to a third party. In order to facilitate the satisfaction of certain conditions to the effectiveness of the DOCA, on November 22, 2024, the Company entered into (i) a Business Transfer Agreement, (ii) a Transitional Services Deed, and (iii) a Deed of Settlement and Release with S&W Australia. The Company also entered into a Deed of Release of US Corporate Guarantee with NAB, and obtained a release of certain applicable liens from CIBC. Business Transfer Agreement Under the Business Transfer Agreement, the Company transferred certain intellectual property rights related to alfalfa and white clover seeds necessary for S&W Australia’s continued operations, or the IP Rights, along with certain related inventory valued at approximately $ 6.0 million, to S&W Australia. The value of the IP Rights is currently being assessed. Pursuant to the agreement, S&W Australia granted the Company a non-exclusive, non-transferable, royalty-bearing license to the IP Rights for the sale of products in the United States, Mexico, Canada, Central America, and South America for a term of five years. S&W Australia is entitled to receive a royalty in the mid-single digits from the Company on gross revenue generated from the licensed IP Rights. Transitional Services Deed Under the Transitional Services Deed, the Company agreed to continue providing certain services it has generally provided to S&W Australia on a temporary basis to support the transition of services from the Company to S&W Australia. Each party will be responsible for its own transition costs. The services provided per the Transitional Services Deed will terminate between February 22, 2025 and August 31, 2025, unless terminated earlier pursuant to its terms. Deed of Settlement and Release Under the Deed of Settlement and Release, in consideration for the Company’s (i) transfers under the Business Transfer Agreement, (ii) services rendered under the Transitional Services Deed and (iii) certain other payments, S&W Australia released the Company from all its net intercompany liabilities and obligations owed to S&W Australia, which is represented in Payable to unconsolidated subsidiary and Receivable from unconsolidated subsidiary in the Company's Condensed Consolidated Balance Sheets as of September 30, 2024. Deed of Release of US Corporate Guarantee Under the Deed of Release of US Corporate Guarantee, NAB released the Company from all liability under the Parent Guarantee related to the NAB Finance Agreement. Lien Release Pursuant to the Company’s Amended CIBC Loan Agreement, CIBC obtained a security interest in the Company’s assets. In connection with the execution of the agreements listed above, CIBC consented to the transfer of, and released its security interests in, the assets of the Company to be transferred to S&W Australia pursuant to the Business Transfer Agreement as described above.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates are adjusted to reflect actual experience when necessary. Significant estimates and assumptions affect many items in the financial statements. In the Annual Report on Form 10-K for the year ended June 30, 2024 filed with this SEC on November 1, 2024, this included the recoverability of long-lived assets and inventory valuation. Significant estimates and assumptions are also used to establish the fair value and useful lives of depreciable tangible and certain intangible assets as well as valuing stock-based compensation. Actual results may differ from those estimates and assumptions, and such results may affect income, financial position or cash flows. The Company believes the estimates and assumptions underlying the accompanying Condensed Consolidated Financial Statements are reasonable and supportable based on the information available at the time the financial statements were prepared. However, certain adverse geopolitical and macroeconomic events, such as the ongoing conflict between Ukraine and Russia and related sanctions, the armed conflict in Sudan, the conflict in the Middle East, the import ban on alfalfa seed in Saudi Arabia, and uncertain market conditions, including higher inflation and supply chain disruptions, have, among other things, negatively impacted the global economy, created significant volatility and disruption of financial markets, and significantly increased economic and demand uncertainty. These factors make many of the estimates and assumptions reflected in these Condensed Consolidated Financial Statements inherently less certain. Therefore, actual results may ultimately differ from those estimates to a greater degree than historically.
Liquidity and Going Concern	Liquidity and Going Concern The Company is not profitable and has recorded negative cash flows from operating activities for the last several years. For the three months ended September 30, 2024, the Company reported a net loss from continuing operations of $ 6.2 million and a net loss from discontinued operations of $ 10.0 million, which included a $ 9.8 million loss from the deconsolidation of S&W Australia. The Company has an accumulated deficit of $ 138.4 million as of September 30, 2024. As of September 30, 2024, the Company had cash on hand of $ 0.5 million and negative working capital of $ 8.3 million. The Company had no unused availability from its working capital facility with CIBC as of September 30, 2024 (see Note 9 - Debt for further discussion). The Company’s Amended and Restated Loan and Security Agreement with CIBC, or the Amended CIBC Loan Agreement, is classified as current on the Company's Condensed Consolidated Balance Sheets given that the debt is due within 12 months of the September 30, 2024. The Amended CIBC Loan Agreement matures on November 30, 2024 , given that we delivered to CIBC by November 8, 2024, an amended letter of credit issued by JPMorgan Chase Bank, N.A. for the account of MFP Partners L.P., extending the letter of credit to December 31, 2024. The Amended CIBC Loan Agreement contains various financial covenants. Adverse geopolitical and macroeconomic events and other factors affecting the Company’s results of operations have increased the risk of the Company’s inability to comply with these covenants, which could result in acceleration of its repayment obligations and foreclosure on its pledged assets. Effective September 16, 2024, and since then, the revolving loan outstanding under the Amended CIBC Loan Agreement (as amended on July 3, 2024) has exceeded the total revolving loan commitment thereunder, which constitutes an event of default. On September 18, 2024, the Company received a reservation of rights letter from CIBC asserting the existence of such event of default, increasing the interest rate applicable to the loans by 2 % per annum (which is the default rate under the Amended CIBC Loan Agreement), and reserving CIBC’s right to immediately exercise any of CIBC’s other rights or remedies under the Amended CIBC Loan Agreement as it deems appropriate. As of the date of this filing, this remains in default and CIBC has not accelerated the indebtedness under the Amended CIBC Loan Agreement. S&W Australia’s entry into voluntary administration constituted an event of default under the Company’s Amended CIBC Loan Agreement, as a result of a cross-default provision in the Amended CIBC Loan Agreement that is triggered by the event of default under the NAB Finance Agreement. On August 5, 2024, the Company received a waiver for the event of default from CIBC, which contained certain stipulations outside of the Company's control and detailed further in Note 1 - General. The voluntary administration process resulted in the transfer of S&W Australia's assets, as noted in Note 15 - Subsequent Events. While we obtained waivers for certain defaults and covenants in the past, there can be no assurance we will be successful in meeting our covenants, avoiding future defaults, or securing future waivers and/or amendments from our lenders. If we are unsuccessful in doing so, as currently is the case with CIBC, we may need to reduce the scope of our operations, repay amounts owing to our lenders, finance our cash needs through a combination of equity and debt financings, enter into collaborations, strategic alliances and licensing arrangements, delay payments to our growers, sell certain assets or divest certain operations. Further, if the Company cannot renew or find other financing options when its debt facility with CIBC expires on November 30, 2024, it may need to reduce the scope of its operations, repay amounts owed to its lenders and/or sell certain assets. Additionally, if the Company is not able to find a buyer for S&W Australia, it may be required to pay the Parent Guarantee, which, in turn, could cause the Company to reduce the scope of its operations, repay amounts owed to its lenders, and/or sell certain assets. These operating and liquidity factors raise substantial doubt regarding the Company’s ability to continue as a going concern. The Company’s Condensed Consolidated Financial Statements do not include any adjustments that might result from the outcome of this uncertainty.
Cost of Revenue	Cost of Revenue The Company records purchasing and receiving costs, inspection costs and warehousing costs in Cost of revenue. When the Company is required to pay for outward freight and/or the costs incurred to deliver products to its customers, the costs are included in Cost of revenue.
Cash and Cash Equivalents	Cash and Cash Equivalents For financial statement presentation purposes, the Company considers time deposits, certificates of deposit and all highly liquid investments with original maturities of three month s or less to be cash and cash equivalents. At times, cash and cash equivalents balances exceed amounts insured by the Federal Deposit Insurance Corporation. Cash balances located outside of the United States may not be insured and totaled $ 0.0 million on September 30, 2024 and June 30, 2024. Cash balances residing in the United States exceeding the Federal Deposit Insurance Corporation limit of $ 250,000 totaled $ 0.2 million and $ 0.0 million on September 30, 2024 and June 30, 2024, respectively.
International Operations	International Operations The Company translates its foreign operations’ assets and liabilities denominated in foreign currencies into U.S. dollars at the current rates of exchange as of the balance sheet date and income and expense items at the average exchange rate for the reporting period. Translation adjustments resulting from exchange rate fluctuations are recorded in the cumulative translation account, a component of accumulated other comprehensive loss. Gains or losses from foreign currency transactions are included in the Condensed Consolidated Statements of Operations. For the three months ended September 30, 2024 and 2023, the Co mpany recognized the following foreign currency transaction gains in Cost of revenue and losses in Foreign currency loss within Other expense (income) in the Condensed Consolidated Statements of Operations: Three Months Ended September 30, 2024 2023 Cost of revenue $ ( 453 ) $ ( 233 ) Foreign currency loss 7,926 570 Total $ 7,473 $ 337
Accounts Receivable	Accounts Receivable The Company provides an allowance for credit losses equal to the estimated uncollectible amounts. Prior to July 1, 2023, that estimate is based on historical collection experience, current economic and market conditions and a review of the current status of each customer’s trade accounts receivable. Effective July 1, 2023, in determining the Company's reserve for credit losses, receivables are assigned an expected loss based on historical information adjusted for forward-looking economic factors. The allowance for credit losses was $ 0.5 million on September 30, 2024 and June 30, 2024.
Inventories	Inventories Inventories consist of seed and packaging materials. Inventories are stated at the lower of cost or net realizable value, and an inventory reserve permanently reduces the cost basis of inventory. Inventories are valued as follows: Actual cost is used to value raw materials such as packaging materials, as well as goods in process. Costs for substantially all finished goods, which include the cost of carryover crops from the previous year, are valued at actual cost. Actual cost for finished goods includes plant conditioning and packaging costs, direct labor and raw materials and manufacturing overhead costs based on normal capacity. The Company records abnormal amounts of idle facility expense, freight, handling costs and wasted material (spoilage) as current period charges and allocates fixed production overhead to the costs of finished goods based on the normal capacity of the production facilities. Inventory is periodically reviewed to determine if it is marketable, obsolete or impaired. Inventory that is determined to be obsolete or impaired is written off to expense at the time the impairment is identified. Inventory quality is a function of germination percentage. Our experience has shown that our alfalfa seed quality tends to be stable under proper storage conditions; therefore, we do not view inventory obsolescence for alfalfa seed as a material concern. Hybrid crops (sorghum and sunflower) seed quality may be affected by warehouse storage pests such as insects and rodents. The Company maintains a strict pest control program to mitigate risk and maximize hybrid seed quality. Components of inventory are as follows: As of September 30, 2024 As of June 30, 2024 Raw materials and supplies $ 1,614,377 $ 1,324,087 Work in progress 8,388,736 2,305,572 Finished goods 16,546,274 18,998,684 Inventories, net $ 26,549,387 $ 22,628,343
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment is depreciated using the straight-line method over the estimated useful life of the asset - periods of 5 to 35 years for buildings, 3 to 20 years for machinery and equipment, 7 to 10 years for leasehold improvements, and 2 to 5 years for vehicles.
Intangible Assets	Intangible Assets Intangible assets acquired in business acquisitions are reported at their initial fair value less accumulated amortization. Intangible assets are amortized using the straight-line method over the estimated useful life of the asset. Periods of 10 to 30 years for technology/IP/germplasm, 5 to 20 years for customer relationships and trade names and 10 to 20 for other intangible assets. The weighted average estimated useful lives are 25 years for technology/IP/germplasm, 19 years for customer relationships, 16 years for trade names, and 18 years for other intangible assets as of September 30, 2024.
Investments	Investments The Company has one partnership resulting in a 34 % ownership interest in Vision Bioenergy. Following the initial recording of this investment, the Company assesses and records its share of equity earnings from the investment on a quarterly basis, resulting in the investment carrying value increasing or decreasing depending on whether a gain or loss is recorded.
Research and Development Costs	Research and Development Costs The Company is engaged in ongoing research and development, or R&D, of proprietary seed varieties. All R&D costs must be charged to expense as incurred. Accordingly, internal R&D costs are expensed as incurred. Third-party R&D costs are expensed when the contracted work has been performed or as milestone results have been achieved. The costs associated with equipment or facilities acquired or constructed for R&D activities that have alternative future uses are capitalized and depreciated on a straight-line basis over the estimated useful life of the asset.
Income Taxes	Income Taxes Deferred tax assets and liabilities are determined based on differences between the financial statement and tax basis of assets and liabilities, as well as a consideration of net operating loss and credit carry forwards, using enacted tax rates in effect for the period in which the differences are expected to impact taxable income. A valuation allowance is established, when necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company’s effective tax rate for the three months ended September 30, 2024 and 2023 ha s been affected by the valuation allowance on the Company’s deferred tax assets.
Net Loss Per Common Share Data	Net Loss Per Common Share Data The Company computes earnings per share using the two-class method. The two-class method requires an earnings allocation formula that determines earnings per share for common shareholders and participating security holders according to dividends declared and participating rights in undistributed earnings. The Company's Series B Preferred Stock and related warrant, or Series B Warrant (see Note 14 - Series B Redeemable Convertible Preferred Stock of the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC), are participating securities because holders of such shares have non-forfeitable dividend rights and participate in any undistributed earnings with common stock. Under the two-class method, total dividends provided to the holders of participating securities and undistributed earnings allocated to participating securities, are subtracted from net income attributable to the Company in determining net loss attributable to common shareholders in the two-class earnings per share, or EPS, calculation. Accretion to the redemption value for the Series B Preferred Stock is also treated as a deemed dividend and subtracted from net income attributable to shareholders. There were no undistributed earnings to allocate to the participating securities in the three months ended September 30, 2024 and 2023. The calculation of net loss per common share is shown in the table below: Three Months Ended September 30, 2024 2023 Numerator: Net loss from continuing operations $ ( 6,235,227 ) $ ( 5,025,030 ) Net loss from discontinued operations ( 9,994,499 ) ( 931,887 ) Net loss ( 16,229,726 ) ( 5,956,917 ) Loss attributable to non-controlling interests — ( 7,288 ) Net loss attributable to S&W Seed Company ( 16,229,726 ) ( 5,949,629 ) Dividends accrued for participating securities ( 102,054 ) ( 94,207 ) Accretion of Series B Preferred Stock redemption value ( 25,838 ) ( 25,838 ) Numerator for net loss per common share - basic and diluted $ ( 16,357,618 ) $ ( 6,069,674 ) Denominator: Denominator for basic and diluted net loss per share - weighted average shares 2,282,780 2,263,643 Net loss per common share - basic and diluted $ ( 7.17 ) $ ( 2.68 ) Anti-dilutive shares, which have been excluded from the computation of diluted loss per share, included 279,670 employee stock options, 67,960 restricted stock units, 89,211 shares issuable upon conversion of the Series B Convertible Preferred Stock, warrants to purchase 138,600 shares of common stock related to the MFP Loan Agreement (as defined below), and 29,440 warrants issued with the Company's Series B Convertible Preferred Stock. The terms and conditions of these securities are more fully described in Note 13 - Equity-Based Compensation and Note 14 - Series B Redeemable Convertible Preferred Stock of the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended June 30, 2024, as filed with the SEC. For the period ended September 30, 2024 and 2023 , all potentially dilutive shares were anti-dilutive and excluded from the calculation of diluted loss per share because net losses were recognized.
Concentrations	Concentrations One customer accounted for 20 % and another customer accounted for an additional 16 % of revenue for the three months ended September 30, 2024. One customer accounted for 22 % and another customer accounted for 18 % of the Company's revenue for the three months ended September 30, 2023. One customer accounted for 15 % and another customer accounted for an additional 10 % of the Company's accounts receivable as of September 30, 2024 and one customer accounted for 17 % and another customer accounted for an additional 16 % of the Company’s accounts receivable as of June 30, 2024. The Company sells a substantial portion of its products to international customers (see Note 5 - Revenue Recognition). Sales to international markets represented 65 % and 72 % of revenue during the three months ended September 30, 2024 and 2023, respectiv ely. The net book value of fixed assets located outside the United States w as 0 % of total fixed assets on September 30, 2024 and June 30, 2023 , respectively, from continuing operations .
Fair Values of Financial Instruments	Fair Value of Financial Instruments The Company discloses assets and liabilities that are recognized and measured at fair value, presented in a three-tier fair value hierarchy, as follows: • Level 1. Observable inputs such as quoted prices in active markets; • Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and • Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The carrying value of cash and cash equivalents, accounts payable, short-term and all long-term borrowings, as reflected in the condensed consolidated balance sheets, approximate fair value because of the short-term maturity of these instruments or interest rates commensurate with market rates. There have been no changes in operations and/or credit characteristics since the date of issuance that could impact the relationship between interest rate and market rates. The Company’s obligations under the Parent Guarantee were not subject to stay in connection with S&W Australia’s voluntary administration and follows the terms of the facilities S&W Australia has with NAB, with the primary borrowing base line expiring on March 31, 2025. As the Company lost control and deconsolidated S&W Australia as a result from the voluntary administration process, the Company must recognize a liability for the fair value of the Parent Guarantee per ASC 460, Guarantees. In order for this any payments to occur, NAB must first make a claim under the Parent Guarantee, which has not occurred as of September 30, 2024. The Company assessed the fair value of the Parent Guarantee as of July 24, 2024 and elected to record the guarantee at fair value at each reporting date, with any changes in fair value being recorded as a gain or loss in the Company's Condensed Consolidated Statements of Operations. The Company obtained an independent valuation, assigning probabilities under various scenarios and applying estimated recovery and discount rates, which resulted in a $ 5.0 million liability being recorded for the Parent Guarantee under Bank guarantee on the Company's Condensed Consolidated Balance Sheets as of July 24, 2024 and September 30, 2024. The Company determined the fair value of the Parent Guarantee based on a scenario analysis, which included a discount rate ranging between 25.4 % and 35.4 % as of July 24, 2024 and 25.5 % and 35.5 % as of September 30, 2024, and a weighted average recovery rate of 57.8 % as of July 24, 2024 and September 30, 2024. As discussed further in Note - 15, Subsequent Events, the Company was released of the Parent Guarantee from NAB on November 22, 2024. In conjunction with the Vision Bioenergy partnership transaction, S&W received a one-time option, or Purchase Option, exercisable at any time on or before the fifth anniversary of the closing of the partnership transaction, to repurchase a 6 % membership interest from Shell. The option repurchase prices range between approximately $ 7.1 and $ 12.0 million, depending on the date on which such purchase is completed. The Purchase Option was valued at $ 0.7 million using a lattice option valuation model. The valuation model incorporated significant, unobservable inputs including a discounted cash flow model based on management projections of future Vision Bioenergy results and an estimate of the current per share value of Vision Bioenergy shares. In the model, the estimate of the current per share value was discounted to account for lack of control and marketability, which were considered to be part of the unit of account given the restrictions of the limited liability com pany agreement that governs the ownership rights of the members. Other unobservable inputs included the risk-free rates and the estimated future stock volatility based on the historical stock price volatilities of other market participants. A full fair value analysis will be performed at each fiscal year-end or when there is an indication that there may be an impairment to the valuation. Management will estimate and adjust the balance for interim periods. A full fair value analysis will be performed whenever there is a potential indicator of impairment to the valuation. No indicators have been identified for the three months ended September 30, 2024 to suggest any material change in the fair value of the purchase option. Quantitative information about Level 3 fair value measurement is as follows: Fair Value as of September 30, 2024 Valuation Technique Unobservable Input Range Purchase Option $ 695,000 Option Model Risk-free rate 3.8 % - 4.9 % Stock price volatility 60 % - 65 % Lack of control premium 13 % Lack of marketability premium 30 % Assets and liabilities that are recognized and measured at fair value on a recurring basis are categorized as follows as of September 30, 2024 and June 30, 2024: Fair Value Measurements as of September 30, 2024: Level 1 Level 2 Level 3 Bank guarantee — — $ 5,000,000 Vision Bioenergy interest purchase option — — 695,000 Total $ — $ — $ 5,695,000 Fair Value Measurements as of June 30, 2024: Level 1 Level 2 Level 3 Vision Bioenergy interest purchase option — — $ 695,000 Total $ — $ — $ 695,000
Recent Adopted Accounting Pronouncements	Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures, or ASU 2023-07, which requires an enhanced disclosure of segments on an annual and interim basis, including the title of the chief operating decision maker, significant segment expenses, and the composition of other segment items for each segment's reported profit. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and adoption of ASU 2023-07 should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of this standard. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures, or ASU 2023-09, expanding the disclosures requirement for income taxes primarily by requiring more detailed disclosure for income taxes paid and the effective tax rate reconciliation. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted, and adoption of ASU 2023-09 can be applied prospectively or retrospectively. The Company is currently evaluating the impact of this standard. We have evaluated all other issued and unadopted Accounting Standards Updates and believe the adoption of these standards will not have a material impact on our condensed consolidated statements of operations, comprehensive income, balance sheets, or cash flows.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Schedule of Foreign Currency Transaction (Gains) Loss	For the three months ended September 30, 2024 and 2023, the Co mpany recognized the following foreign currency transaction gains in Cost of revenue and losses in Foreign currency loss within Other expense (income) in the Condensed Consolidated Statements of Operations: Three Months Ended September 30, 2024 2023 Cost of revenue $ ( 453 ) $ ( 233 ) Foreign currency loss 7,926 570 Total $ 7,473 $ 337
Components of Inventory	Components of inventory are as follows: As of September 30, 2024 As of June 30, 2024 Raw materials and supplies $ 1,614,377 $ 1,324,087 Work in progress 8,388,736 2,305,572 Finished goods 16,546,274 18,998,684 Inventories, net $ 26,549,387 $ 22,628,343
Schedule of Calculation of Net Loss Per Common Share	The calculation of net loss per common share is shown in the table below: Three Months Ended September 30, 2024 2023 Numerator: Net loss from continuing operations $ ( 6,235,227 ) $ ( 5,025,030 ) Net loss from discontinued operations ( 9,994,499 ) ( 931,887 ) Net loss ( 16,229,726 ) ( 5,956,917 ) Loss attributable to non-controlling interests — ( 7,288 ) Net loss attributable to S&W Seed Company ( 16,229,726 ) ( 5,949,629 ) Dividends accrued for participating securities ( 102,054 ) ( 94,207 ) Accretion of Series B Preferred Stock redemption value ( 25,838 ) ( 25,838 ) Numerator for net loss per common share - basic and diluted $ ( 16,357,618 ) $ ( 6,069,674 ) Denominator: Denominator for basic and diluted net loss per share - weighted average shares 2,282,780 2,263,643 Net loss per common share - basic and diluted $ ( 7.17 ) $ ( 2.68 )
Schedule of Quantitative Information About Level 3 Fair Value Measurement	Quantitative information about Level 3 fair value measurement is as follows: Fair Value as of September 30, 2024 Valuation Technique Unobservable Input Range Purchase Option $ 695,000 Option Model Risk-free rate 3.8 % - 4.9 % Stock price volatility 60 % - 65 % Lack of control premium 13 % Lack of marketability premium 30 %
Schedule of Assets and Liabilities Recognized and Measured at Fair Value on Recurring Basis	Assets and liabilities that are recognized and measured at fair value on a recurring basis are categorized as follows as of September 30, 2024 and June 30, 2024: Fair Value Measurements as of September 30, 2024: Level 1 Level 2 Level 3 Bank guarantee — — $ 5,000,000 Vision Bioenergy interest purchase option — — 695,000 Total $ — $ — $ 5,695,000 Fair Value Measurements as of June 30, 2024: Level 1 Level 2 Level 3 Vision Bioenergy interest purchase option — — $ 695,000 Total $ — $ — $ 695,000

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Summary of the Discontinued Operations	Accordingly, the operating results of the discontinued operations for the three months ended September 30, 2024 and 2023 are presented in the Condensed Consolidated Statements of Operations within Net loss from discontinued operations. For the three months ended September 30, 2024, this includes S&W Australia activity from July 1, 2024 through July 24, 2024, the date the Company no longer controlled and deconsolidated S&W Australia. A reconciliation to Net loss from discontinued operations is as follows: Three Months Ended September 30, 2024 2023 Revenue $ 842,545 $ 5,675,119 Cost of revenue (excluding depreciation and amortization shown separately below) 572,862 3,388,955 Gross profit 269,683 2,286,164 Operating expenses Selling, general and administrative expenses 276,096 1,633,018 Research and development expenses 50,713 307,623 Depreciation and amortization 47,660 262,187 Loss (gain) on disposal of property, plant and equipment 25,696 ( 10,864 ) Total operating expenses 400,165 2,191,964 (Loss) income from operations ( 130,482 ) 94,200 Other (income) expense Loss on deconsolidation of subsidiary 9,828,253 — Foreign currency (gain) loss ( 120,877 ) 371,619 Interest expense - amortization of debt discount 6,799 99,007 Interest expense, net 149,842 457,039 Net loss from discontinued operations before income taxes ( 9,994,499 ) ( 833,465 ) Provision for income taxes from discontinued operations — 13,499 Net loss from discontinued operations before equity in net earnings of affiliates ( 9,994,499 ) ( 846,964 ) Equity in loss of equity method investee, net of tax, from discontinued operations — 84,923 Net loss from discontinued operations $ ( 9,994,499 ) $ ( 931,887 ) The following table presents assets and liabilities of discontinued operations as of June 30, 2024: ASSETS As of June 30, 2024 CURRENT ASSETS Cash and cash equivalents $ 7,506 Accounts receivable, net 6,228,502 Inventories, net 15,478,760 Prepaid expenses and other current assets 676,923 CURRENT ASSETS OF DISCONTINUED OPERATIONS 22,391,691 NON-CURRENT ASSETS Property, plant and equipment, net 3,540,075 Intangibles, net 576,669 Right of use assets - operating leases 1,134,985 Other assets 327,212 NON-CURRENT ASSETS OF DISCONTINUED OPERATIONS 5,578,941 TOTAL ASSETS OF DISCONTINUED OPERATIONS $ 27,970,632 LIABILITIES CURRENT LIABILITIES Accounts payable $ 10,235,898 Deferred revenue 40,456 Accrued expenses and other current liabilities 3,123,721 Current portion of working capital lines of credit, net 27,549,620 Current portion of long-term debt, net 3,943,804 CURRENT LIABILITIES OF DISCONTINUED OPERATIONS 44,893,499 Long-term debt, net, less current portion 151,387 Other non-current liabilities 778,236 NON-CURRENT LIABILITIES OF DISCONTINUED OPERATIONS 929,623 TOTAL LIABILITIES OF DISCONTINUED OPERATIONS $ 45,823,122
Schedule of Reconciliation of Loss on Deconsolidation of S&W Australia	Below is a reconciliation of the loss on deconsolidation of S&W Australia: As of July 24, 2024 Realization of currency translation adjustments from accumulated other comprehensive loss $ 7,289,430 Recognition of bank guarantee (see Note 1) 5,000,000 S&W Australia total assets 43,168,611 S&W Australia total liabilities ( 45,629,788 ) Loss on deconsolidation of subsidiary $ 9,828,253 A reconciliation of S&W Australia total assets and total liabilities as of July 24, 2024 is as follows: As of July 24, 2024 CURRENT ASSETS Cash and cash equivalents $ 85,876 Accounts receivable, net 6,311,994 Receivable from unconsolidated subsidiary 15,549,595 Inventories, net 15,274,546 Prepaid expenses and other current assets 666,509 TOTAL CURRENT ASSETS 37,888,520 Property, plant and equipment, net 3,322,273 Other intangibles, net 554,850 Right of use assets - operating leases 1,093,946 Other assets 309,022 TOTAL ASSETS $ 43,168,611 CURRENT LIABILITIES Accounts payable $ 9,150,910 Payable to unconsolidated subsidiary 520,213 Deferred revenue 33,047 Accrued expenses and other current liabilities 2,947,985 Current portion of working capital lines of credit, net 28,263,338 Current portion of long-term debt, net 3,828,839 TOTAL CURRENT LIABILITIES 44,744,332 Long-term debt, net, less current portion 127,288 Other non-current liabilities 758,168 TOTAL LIABILITIES $ 45,629,788

Leases (Tables)

Leases (Tables)	3 Months Ended
	Sep. 30, 2024
Lessee Disclosure [Abstract]
Summary of Components of Lease Assets and Liabilities	The components of lease assets and liabilities as of September 30, 2024 and June 30, 2024 are as follows: Leases Balance Sheet Classification: As of September 30, 2024 As of June 30, 2024 Assets: Right of use assets - finance leases $ 1,050,072 $ 1,086,667 Accumulated amortization - finance leases ( 553,172 ) ( 499,275 ) Right of use assets - finance leases, net Other assets 496,900 587,392 Right of use assets - operating leases Right of use assets - operating leases 890,086 1,113,833 Total lease assets $ 1,386,986 $ 1,701,225 Liabilities: Current lease liabilities - finance leases Current portion of long-term debt, net $ 295,671 $ 314,980 Current lease liabilities - operating leases Accrued expenses and other current liabilities 327,048 380,492 Long-term portion of lease liabilities - Long-term debt, net, less current portion 223,454 303,395 Long-term portion of lease liabilities - Other non-current liabilities 659,996 800,620 Total lease liabilities $ 1,506,169 $ 1,799,487
Summary of Components of Lease Cost	The components of lease cost are as follows: Three Months Ended September 30, Lease cost: Income Statement Classification: 2024 2023 Operating lease cost Cost of revenue $ 60,766 $ 60,944 Operating lease cost Selling, general and administrative expenses 33,026 36,542 Operating lease cost Research and development expenses 21,310 37,135 Finance lease cost Depreciation and amortization 57,386 67,497 Finance lease cost Interest expense, net 14,163 10,036 Total lease costs $ 186,651 $ 212,154
Summary of Maturities of Lease Liabilities	Maturities of lease liabilities as of September 30, 2024, are as follows: Fiscal Year Operating Leases Finance Leases Remainder of 2025 $ 311,147 $ 247,175 2026 354,960 277,359 2027 241,622 44,615 2028 183,599 — 2029 56,967 — Total lease payments 1,148,295 569,149 Less: Interest ( 161,251 ) ( 50,024 ) Present value of lease liabilities $ 987,044 $ 519,125
Summary of Weighted Average Assumptions on Lease Term and Discount Rate and Supplemental Cash Flow Information Related to Leases	The following are the weighted average assumptions used for lease term and discount rate and supplemental cash flow information related to leases as of September 30, 2024: As of September 30, 2024 Operating lease remaining lease term 3.3 years Operating lease discount rate 8.53 % Finance lease remaining lease term 1.6 years Finance lease discount rate 9.48 % Cash paid for operating leases $ 114,089 Cash paid for finance leases $ 105,709

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Sep. 30, 2024
Revenues [Abstract]
Schedule of Disaggregation of Revenues	The Company disaggregates revenue by type of contract and by destination country. The following table shows revenue from external sources by type of contract: Three Months Ended September 30, 2024 2023 Seed sales: Alfalfa $ 6,708,003 $ 7,086,370 Sorghum 1,432,857 3,509,966 Other 11,224 ( 46,649 ) Services 157,392 207,660 Total revenue $ 8,309,476 $ 10,757,347
Schedule of Revenues and Percentage of Revenue from External Customers by Country	The following tables show revenue and percentage of revenue from external sou rces by destination country: Three Months Ended September 30, 2024 2023 United States $ 2,934,716 35 % $ 3,014,244 28 % Libya 1,295,550 16 % 1,072,800 10 % Mexico 1,052,781 13 % 1,562,814 9 % Sudan 807,530 10 % 1,267,933 12 % South Africa 533,125 6 % 1,195,553 11 % Egypt 496,360 6 % — 0 % Uganda 299,640 4 % 40,000 0 % Morocco 287,994 3 % — 0 % Qatar 148,574 2 % 58,500 1 % Argentina 89,289 1 % 35,400 0 % Saudi Arabia — 0 % 2,208,738 26 % Other 363,917 4 % 301,365 3 % Total revenue $ 8,309,476 100 % $ 10,757,347 100 %

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consist of the following: Balance at June 30, 2024 Balance at September 30, 2024 Gross Carrying Amount Accumulated Amortization Net Amortization Gross Carrying Amount Accumulated Amortization Net Intellectual property $ 33,325,737 $ ( 13,060,119 ) $ 20,265,618 $ ( 346,229 ) $ 33,325,737 $ ( 13,406,348 ) $ 19,919,389 Trade name 1,831,928 ( 1,178,972 ) 652,956 ( 21,120 ) 1,831,928 ( 1,200,092 ) 631,836 Customer relationships 1,596,653 ( 1,019,623 ) 577,030 ( 22,602 ) 1,596,653 ( 1,042,225 ) 554,428 GI customer list 121,786 ( 93,131 ) 28,655 ( 1,791 ) 121,786 ( 94,922 ) 26,864 Supply agreement 1,512,667 ( 888,692 ) 623,975 ( 18,908 ) 1,512,667 ( 907,600 ) 605,067 Grower relationships 2,343,977 ( 1,223,208 ) 1,120,769 ( 26,352 ) 2,343,977 ( 1,249,560 ) 1,094,417 Internal use software 677,776 ( 474,441 ) 203,335 ( 16,944 ) 677,776 ( 491,385 ) 186,391 $ 41,410,524 $ ( 17,938,186 ) $ 23,472,338 $ ( 453,946 ) $ 41,410,524 $ ( 18,392,132 ) $ 23,018,392
Intangible Assets (Future Amortization)	Estimated aggregate remaining amortization is as follows: Remainder of 2025 2026 2027 2028 2029 Thereafter Amortization expense $ 1,343,921 $ 1,714,386 $ 1,663,502 $ 1,606,211 $ 1,586,728 $ 15,103,644

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	3 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Components of Property, Plant and Equipment	Components of property, plant and equipment were as follows: As of September 30, 2024 As of June 30, 2024 Land and improvements $ 586,849 $ 586,849 Buildings and improvements 2,365,835 2,371,565 Machinery and equipment 8,785,882 8,621,280 Vehicles 663,778 648,836 Leasehold improvements 473,307 552,810 Construction in progress 3,341 28,453 Total property, plant and equipment 12,878,992 12,809,793 Less: accumulated depreciation ( 6,898,367 ) ( 6,682,595 ) Property, plant and equipment, net $ 5,980,625 $ 6,127,198

Investments (Tables)

Investments (Tables)	3 Months Ended
	Sep. 30, 2024
Schedule of Equity Method Investments [Line Items]
Summary of Equity Method Investments	The following summarizes the carrying amount of the Company's equity method investments reflected in the Condensed Consolidated Balance Sheets: As of September 30, 2024 As of June 30, 2024 Carrying Amount Economic Interest Carrying Amount Economic Interest Vision Bioenergy $ 18,847,331 34 % $ 19,694,209 34 % Total equity method investments $ 18,847,331 $ 19,694,209
Schedule of Company's Equity Method Investments	For the three month s ended September 30, 2024, the following activity occurred in the Company's equity method investments: Vision Bioenergy Carrying amount at June 30, 2024 $ 19,694,209 Equity in loss of equity method investment ( 846,878 ) Carrying amount at September 30, 2024 $ 18,847,331
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Summary of Equity Method Investments	The summarized unaudited balance sheet presented below reflects the financial information of Vision Bioenergy as of September 30, 2024 and June 30, 2024: As of September 30, 2024 (Unaudited) As of June 30, 2024 (Unaudited) Cash $ 4,523,734 $ 6,327,459 Other current assets 6,689,246 3,138,627 Fixed assets 17,818,133 17,866,091 Intangible assets 18,976,035 19,624,187 Goodwill 11,564,157 11,564,157 Other assets 155,214 235,613 TOTAL ASSETS $ 59,726,519 $ 58,756,134 Current liabilities $ 4,957,388 $ 1,485,283 Long-term liabilities 77,845 133,070 Equity 54,691,286 57,137,781 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 59,726,519 $ 58,756,134 The summarized unaudited income statement presented below reflects the financial information of Vision Bioenergy for the three months ended September 30, 2024 and 2023: Three Months Ended September 30, 2024 (Unaudited) 2023 (Unaudited) Revenue $ 307,772 $ 110,900 Gross loss ( 486,271 ) ( 549,607 ) Loss from operations ( 2,497,925 ) ( 2,432,762 ) Net loss ( 2,446,495 ) ( 2,362,135 )

Debt (Tables)

Debt (Tables)	3 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Total Debt Outstanding	Total debt outstanding is presented on the Company's Condensed Consolidated Balance Sheets as follows: As of September 30, 2024 As of June 30, 2024 Current portion of working capital lines of credit CIBC $ 16,169,873 $ 16,279,194 Debt issuance costs ( 55,373 ) ( 104,657 ) Total working capital lines of credit, net $ 16,114,500 $ 16,174,537 Current portion of long-term debt Finance leases $ 295,671 $ 314,980 Vehicle loans - Ford Credit 95,096 106,852 Debt issuance costs ( 106,528 ) ( 106,528 ) Total current portion, net $ 284,239 $ 315,304 Long-term debt, less current portion Finance leases $ 223,454 $ 303,395 Vehicle loans - Ford Credit 205,674 222,063 Secured real estate note - AgAmerica 4,300,000 4,300,000 Debt issuance costs ( 76,759 ) ( 103,609 ) Total long-term portion, net $ 4,652,369 $ 4,721,849 Total debt, net $ 4,936,608 $ 5,037,153
Schedule of Annual Maturities of Long-Term Debt Excluding Finance Lease Liabilities	The annual maturities of long-term debt, excluding finance lease liabilities, are as follows: Fiscal Year Amount Remainder of 2025 $ 95,096 2026 4,395,096 2027 95,096 2028 15,482 Total $ 4,600,770

Business Segments (Tables)

Business Segments (Tables)	3 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Summary of Business Activity by Segment	Below is a summary of business activity by segment that is reviewed by the Company's Chief Operating Decision Maker for the three months ended September 30, 2024 and 2023: Three Months Ended September 30, 2024 2023 Revenue Americas $ 4,132,935 $ 4,854,052 International 4,089,006 5,903,295 Other 87,535 — Revenue 8,309,476 10,757,347 Gross profit (excluding depreciation and amortization) Americas 728,263 952,325 International 797,183 1,773,768 Other ( 189,078 ) ( 943 ) Gross profit (excluding depreciation and amortization) $ 1,336,368 $ 2,725,150

Equity-Based Compensation (Tabl

Equity-Based Compensation (Tables)	3 Months Ended
	Sep. 30, 2024
Summary of Stock Option Activity	A summary of stock option activity for the three months ended September 30, 2024 is presented below: Number of Weighted - Weighted- Aggregate Outstanding at June 30, 2024 279,670 $ 39.14 6.8 $ — Granted — — — — Exercised — — — — Canceled/forfeited/expired — — — — Outstanding at September 30, 2024 279,670 $ 39.14 6.5 $ — Options vested and exercisable at September 30, 2024 241,434 $ 42.67 6.2 $ — Options vested and expected to vest at September 30, 2024 279,422 $ 39.20 6.5 $ —
Summary of Activity Related to Non-Vested Restricted Stock Units	A summary of activity related to non-vested restricted stock units is presented below: Number of Weighted-Average Weighted-Average Nonvested restricted units outstanding at June 30, 2024 64,595 $ 11.40 1.2 Granted 5,246 11.34 0.3 Vested ( 1,881 ) 17.04 — Nonvested restricted units outstanding at September 30, 2024 67,960 10.83 1.14

Series B Redeemable Convertib_2

Series B Redeemable Convertible Preferred Stock (Tables)	3 Months Ended
	Sep. 30, 2024
Temporary Equity Disclosure [Abstract]
Summary of Changes to Series B Convertible Preferred Stock	The following summarizes changes to the Series B Convertible Preferred Stock: Balance at June 30, 2024 $ 5,768,765 Dividends accrued 102,054 Accretion of discount for warrants 25,838 Balance at September 30, 2024 $ 5,896,657

Non-Cash Activities for State_2

Non-Cash Activities for Statements of Cash Flows (Tables)	3 Months Ended
	Sep. 30, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Condensed Consolidated Statements of Cash Flows for Non-Cash Activities	The below table represents supplemental information to the Company’s condensed consolidated statements of cash flows for non-cash activities during the three months ended September 30, 2024 and 2023, respectively, for continuing operations, unless otherwise specified: Three Months Ended September 30, 2024 2023 Non-cash investing activities: ROU assets financed by lease liabilities and lease modifications and reassessments $ ( 106,838 ) $ 487,611 Non-cash financing activities: Dividends accrued for participating securities 102,054 94,207 Accretion of discount for Series B preferred stock warrants 25,838 25,838

General - Additional Informatio

General - Additional Information (Details) $ in Millions			3 Months Ended
	Oct. 17, 2024	Oct. 04, 2024	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 AUD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)
Background And Organizations [Line Items]
Total assets			$ 96,611,154			$ 120,725,541
Total liabilities			60,193,305			75,694,416
Stockholders' equity			30,521,192	$ 62,828,906		39,262,360	$ 68,823,433
Revenue			8,309,476	10,757,347
Net loss			(16,229,726)	(5,949,629)
Common Stock [Member]
Background And Organizations [Line Items]
Stockholders' equity			43,398	$ 43,048		$ 43,369	$ 43,004
Common Stock [Member] | Subsequent Event
Background And Organizations [Line Items]
Reverse stock split ratio	0.053	0.053
National Australia Bank Limited
Background And Organizations [Line Items]
Line of guaranteed, maximum borrowing capacity			$ 10,400,000		$ 15

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details)							3 Months Ended
	Oct. 31, 2024	Sep. 18, 2024	Jul. 24, 2024 USD ($)	Jul. 03, 2024	Mar. 22, 2023	Feb. 06, 2023 USD ($)	Sep. 30, 2024 USD ($) shares	Sep. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Cash balances							$ 200,000		$ 0
Bank guarantee							5,000,000		0
Net loss from continuing operations							6,235,227	$ 5,025,030
Net loss from discontinued operations							(9,994,499)	(931,887)
Accumulated deficit							(138,448,097)		(122,090,479)
Cash on hand							500,000
Negative working capital							(8,300,000)
Line of credit facility, remaining borrowing capacity							0
Dividends accrued undistributed earnings to allocate to participating securities							0	0
Federal deposit cash							250,000
S&W Seed Company Australia Pty Ltd | Discontinued Operations
Summary Of Significant Accounting Policies [Line Items]
Bank guarantee			$ 5,000,000
Net loss from discontinued operations							(9,994,499)	$ (931,887)
Loss on deconsolidation of subsidiary			$ 9,828,253				9,828,253
Subsequent Event
Summary Of Significant Accounting Policies [Line Items]
Debt instrument, maturity date	Dec. 31, 2024
CIBC
Summary Of Significant Accounting Policies [Line Items]
Increased applicable interest rate margin on advances		2%
Debt instrument, maturity date				Oct. 31, 2024	Aug. 31, 2024
CIBC | Subsequent Event
Summary Of Significant Accounting Policies [Line Items]
Debt instrument, maturity date	Nov. 30, 2024
Shell
Summary Of Significant Accounting Policies [Line Items]
Membership interest repurchase percent						6%
Fair market value of purchase option							$ 700,000
Employee Stock Options
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares							279,670
Series B Convertible Preferred Stock
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares							89,211
Shares of Common Stock Related to MFP Loan Agreement
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares							138,600
Warrants Issued with Series B Convertible Preferred Stock
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares							29,440
Restricted Stock Units (RSUs)
Summary Of Significant Accounting Policies [Line Items]
Anti-dilutive shares, excluded from computation of diluted loss per share | shares							67,960
Technology/IP/germplasm
Summary Of Significant Accounting Policies [Line Items]
Useful life							25 years
Customer Relationships
Summary Of Significant Accounting Policies [Line Items]
Useful life							19 years
Trade Name
Summary Of Significant Accounting Policies [Line Items]
Useful life							16 years
Other Intangibles
Summary Of Significant Accounting Policies [Line Items]
Useful life							18 years
Non-US
Summary Of Significant Accounting Policies [Line Items]
Cash balances							$ 0		$ 0
Minimum | Discount Rate
Summary Of Significant Accounting Policies [Line Items]
Measurement input			25.4				25.5
Minimum | Shell
Summary Of Significant Accounting Policies [Line Items]
Membership interest repurchase price						$ 7,100,000
Minimum | Technology/IP/germplasm
Summary Of Significant Accounting Policies [Line Items]
Useful life							10 years
Minimum | Customer Relationships
Summary Of Significant Accounting Policies [Line Items]
Useful life							5 years
Minimum | Other Intangibles
Summary Of Significant Accounting Policies [Line Items]
Useful life							10 years
Minimum | Buildings
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives							5 years
Minimum | Machinery and Equipment
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives							3 years
Minimum | Leasehold improvements
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives							7 years
Minimum | Vehicles
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives							2 years
Maximum | Discount Rate
Summary Of Significant Accounting Policies [Line Items]
Measurement input			35.4				35.5
Maximum | Shell
Summary Of Significant Accounting Policies [Line Items]
Membership interest repurchase price						$ 12,000,000
Maximum | Technology/IP/germplasm
Summary Of Significant Accounting Policies [Line Items]
Useful life							30 years
Maximum | Customer Relationships
Summary Of Significant Accounting Policies [Line Items]
Useful life							20 years
Maximum | Other Intangibles
Summary Of Significant Accounting Policies [Line Items]
Useful life							20 years
Maximum | Buildings
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives							35 years
Maximum | Machinery and Equipment
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives							20 years
Maximum | Leasehold improvements
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives							10 years
Maximum | Vehicles
Summary Of Significant Accounting Policies [Line Items]
Estimated useful lives							5 years
Weighted Average | Recovery Rate
Summary Of Significant Accounting Policies [Line Items]
Measurement input			57.8				57.8
Vision Bioenergy
Summary Of Significant Accounting Policies [Line Items]
Sale of ownership interest percentage							34%		34%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Accounts Receivable) - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024
Accounting Policies [Abstract]
Allowance for credit losses	$ 0.5	$ 0.5

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Concentrations) - Additional Information (Details) - Customer	3 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Non-US
Summary Of Significant Accounting Policies [Line Items]
Disclosure on geographic areas, fixed assets	The net book value of fixed assets located outside the United States was 0% of total fixed assets on September 30, 2024 and June 30, 2023, respectively, from continuing operations
Concentration of risk fixed assets amount geographic area, percent of total	0%			0%
Revenue | Geographic Concentration Risk | Non-US
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	65%	72%
Customer One | Revenue | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	20%	22%
Customer One | Accounts Receivable | Credit Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	15%		17%
Customer Two | Revenue | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	16%	18%
Customer Two | Accounts Receivable | Credit Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	10%		16%
Significant Customer | Revenue | Customer Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Number of customers	2	2
Significant Customer | Accounts Receivable | Credit Concentration Risk
Summary Of Significant Accounting Policies [Line Items]
Number of customers	2		2

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule of Foreign Currency Transaction (Gains) Loss (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gains in cost of revenue and losses in foreign currency loss	$ 7,473	$ 337
Cost of Revenue
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gains in cost of revenue and losses in foreign currency loss	(453)	(233)
Foreign currency loss
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gains in cost of revenue and losses in foreign currency loss	$ 7,926	$ 570

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Components of Inventory (Details) - USD ($)	Sep. 30, 2024	Jun. 30, 2024
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 1,614,377	$ 1,324,087
Work in progress	8,388,736	2,305,572
Finished goods	16,546,274	18,998,684
Inventories, net	$ 26,549,387	$ 22,628,343

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Schedule of Calculation of Net Loss Per Common Share (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Numerator:
Net loss from continuing operations	$ (6,235,227)	$ (5,025,030)
Net loss from discontinued operations	(9,994,499)	(931,887)
Net loss	(16,229,726)	(5,956,917)
Loss attributable to non-controlling interests		(7,288)
Net loss attributable to S&W Seed Company	(16,229,726)	(5,949,629)
Dividends accrued for participating securities	(102,054)	(94,207)
Accretion of Series B Preferred Stock redemption value	(25,838)	(25,838)
Numerator for net loss per common share - basic	(16,357,618)	(6,069,674)
Numerator for net loss per common share - diluted	$ (16,357,618)	$ (6,069,674)
Denominator:
Denominator for basic net loss per share - weighted average shares	2,282,780	2,263,643
Denominator for diluted net loss per share - weighted average shares	2,282,780	2,263,643
Less: weighted average shares - dilutive securities:
Net loss per common share - basic	$ (7.17)	$ (2.68)
Net loss per common share - diluted	$ (7.17)	$ (2.68)

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Schedule of Quantitative Information About Level 3 Fair Value Measurement (Details)	Sep. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Asset, Valuation Technique [Extensible Enumeration]	us-gaap:ValuationTechniqueOptionPricingModelMember
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Purchase option	$ 695,000	$ 695,000
Risk-free rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.038
Risk-free rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.049
Stock price volatility | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.60
Stock price volatility | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.65
Lack of control premium
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.13
Lack of marketability premium
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset, measurement input	0.30

Summary of Significant Accou_11

Summary of Significant Accounting Policies - Schedule of Assets and Liabilities Recognized and Measured at Fair Value on Recurring Basis (Details) - USD ($)	Sep. 30, 2024	Jun. 30, 2024
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Bank guarantee	$ 5,000,000	$ 0
Level 1
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Bank guarantee	0
Vision Bioenergy interest purchase option	0	0
Total	0	0
Level 2
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Bank guarantee	0
Vision Bioenergy interest purchase option	0	0
Total	0	0
Level 3
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Bank guarantee	5,000,000
Vision Bioenergy interest purchase option	695,000	695,000
Total	$ 5,695,000	$ 695,000

Discontinued Operations - Summa

Discontinued Operations - Summary of the Operating Results of the Discontinued Operations (Details) - USD ($)		3 Months Ended
	Jul. 24, 2024	Sep. 30, 2024	Sep. 30, 2023
Other (income) expense
Net loss from discontinued operations		$ (9,994,499)	$ (931,887)
S&W Seed Company Australia Pty Ltd | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue		842,545	5,675,119
Cost of revenue (excluding depreciation and amortization shown separately below)		572,862	3,388,955
Gross profit		269,683	2,286,164
Operating expenses
Selling, general and administrative expenses		276,096	1,633,018
Research and development expenses		50,713	307,623
Depreciation and amortization		47,660	262,187
Loss (gain) on disposal of property, plant and equipment		25,696	(10,864)
Total operating expenses		400,165	2,191,964
(Loss) Income from operations		(130,482)	94,200
Other (income) expense
Foreign currency (gain) loss		(120,877)	371,619
Loss on deconsolidation of subsidiary	$ 9,828,253	9,828,253
Interest expense - amortization of debt discount		6,799	99,007
Interest expense, net		149,842	457,039
Net loss from discontinued operations before income taxes		(9,994,499)	(833,465)
Provision for income taxes from discontinued operations			13,499
Net loss from discontinued operations before equity in net earnings of affiliates		(9,994,499)	(846,964)
Equity in loss of equity method investee, net of tax, from discontinued operations			84,923
Net loss from discontinued operations		$ (9,994,499)	$ (931,887)

Discontinued Operations - Sum_2

Discontinued Operations - Summary of Assets and Liabilities of the Discontinued Operations (Details) - USD ($)	Sep. 30, 2024	Jul. 24, 2024	Jun. 30, 2024
CURRENT ASSETS
TOTAL CURRENT ASSETS	$ 0		$ 22,391,691
NON-CURRENT ASSETS
NON-CURRENT ASSETS OF DISCONTINUED OPERATIONS	0		5,578,941
CURRENT LIABILITIES
CURRENT LIABILITIES OF DISCONTINUED OPERATIONS	0		44,893,499
NON-CURRENT LIABILITIES OF DISCONTINUED OPERATIONS	$ 0		929,623
S&W Seed Company Australia Pty Ltd | Discontinued Operations
CURRENT ASSETS
Cash and cash equivalents		$ 85,876	7,506
Accounts receivable, net		6,311,994	6,228,502
Inventories, net		15,274,546	15,478,760
Prepaid expenses and other current assets		666,509	676,923
TOTAL CURRENT ASSETS		37,888,520	22,391,691
NON-CURRENT ASSETS
Property, plant and equipment, net		3,322,273	3,540,075
Intangibles, net		554,850	576,669
Right of use assets - operating leases		1,093,946	1,134,985
Other assets		309,022	327,212
NON-CURRENT ASSETS OF DISCONTINUED OPERATIONS			5,578,941
TOTAL ASSETS OF DISCONTINUED OPERATIONS		43,168,611	27,970,632
CURRENT LIABILITIES
Accounts payable		9,150,910	10,235,898
Deferred revenue		33,047	40,456
Accrued expenses and other current liabilities		2,947,985	3,123,721
Current portion of working capital lines of credit, net		28,263,338	27,549,620
Current portion of long-term debt, net		3,828,839	3,943,804
CURRENT LIABILITIES OF DISCONTINUED OPERATIONS		44,744,332	44,893,499
Long-term debt, net, less current portion		127,288	151,387
Other non-current liabilities		758,168	778,236
NON-CURRENT LIABILITIES OF DISCONTINUED OPERATIONS			929,623
TOTAL LIABILITIES OF DISCONTINUED OPERATIONS		$ 45,629,788	$ 45,823,122

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Details) - S&W Seed Company Australia Pty Ltd - Discontinued Operations - USD ($)		3 Months Ended
	Jul. 24, 2024	Sep. 30, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on deconsolidation of subsidiary	$ (9,828,253)	$ (9,828,253)
Maximum
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Voluntary administration process related material amount		$ 100,000

Discontinued Operations - Sched

Discontinued Operations - Schedule of Reconciliation of Loss On Deconsolidation of S&W Australia (Details) - USD ($)		3 Months Ended
	Jul. 24, 2024	Sep. 30, 2024	Jun. 30, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Recognition of bank guarantee (see Note 1)		$ 5,000,000	$ 0
S&W Seed Company Australia Pty Ltd | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realization of currency translation adjustments from accumulated other comprehensive loss	$ 7,289,430
Recognition of bank guarantee (see Note 1)	5,000,000
S&W Australia total assets	43,168,611		27,970,632
S&W Australia total liabilities	(45,629,788)		$ (45,823,122)
Loss on deconsolidation of subsidiary	$ 9,828,253	$ 9,828,253

Discontinued Operations - Recon

Discontinued Operations - Reconciliation of S&W Australia Total Assets and Total Liabilities (Details) - USD ($)	Sep. 30, 2024	Jul. 24, 2024	Jun. 30, 2024
CURRENT ASSETS
TOTAL CURRENT ASSETS	$ 0		$ 22,391,691
Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]
CURRENT LIABILITIES OF DISCONTINUED OPERATIONS	$ 0		44,893,499
S And W Seed Company Australia Pty Limited [Member] | Discontinued Operations [Member]
CURRENT ASSETS
Cash and cash equivalents		$ 85,876	7,506
Accounts receivable, net		6,311,994	6,228,502
Receivable from unconsolidated subsidiary		15,549,595
Inventories, net		15,274,546	15,478,760
Prepaid expenses and other current assets		666,509	676,923
TOTAL CURRENT ASSETS		37,888,520	22,391,691
Property, plant and equipment, net		3,322,273	3,540,075
Other intangibles, net		554,850	576,669
Right of use assets - operating leases		1,093,946	1,134,985
Other assets		309,022	327,212
TOTAL ASSETS OF DISCONTINUED OPERATIONS		43,168,611	27,970,632
Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]
Accounts payable		9,150,910	10,235,898
Payable to unconsolidated subsidiary		520,213
Deferred revenue		33,047	40,456
Accrued expenses and other current liabilities		2,947,985	3,123,721
Current portion of working capital lines of credit, net		28,263,338	27,549,620
Current portion of long-term debt, net		3,828,839	3,943,804
CURRENT LIABILITIES OF DISCONTINUED OPERATIONS		44,744,332	44,893,499
Long-term debt, net, less current portion		127,288	151,387
Other non-current liabilities		758,168	778,236
TOTAL LIABILITIES OF DISCONTINUED OPERATIONS		$ 45,629,788	$ 45,823,122

Leases - Summary of Components

Leases - Summary of Components of Lease Assets and Liabilities (Details) - USD ($)	Sep. 30, 2024	Jun. 30, 2024
Lessee Disclosure [Abstract]
Right of use assets - finance leases	$ 1,050,072	$ 1,086,667
Accumulated amortization - finance leases	(553,172)	(499,275)
Right of use assets - finance leases, net	$ 496,900	$ 587,392
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets	Other assets
Right of use assets - operating leases	$ 890,086	$ 1,113,833
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Right of use assets - operating leases	Right of use assets - operating leases
Total lease assets	$ 1,386,986	$ 1,701,225
Current lease liabilities - finance leases	$ 295,671	$ 314,980
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Current portion of long-term debt, net	Current portion of long-term debt, net
Current lease liabilities - operating leases	$ 327,048	$ 380,492
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Long-term portion of lease liabilities - finance leases	$ 223,454	$ 303,395
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term debt, net, less current portion	Long-term debt, net, less current portion
Long-term portion of lease liabilities - operating leases	$ 659,996	$ 800,620
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other non-current liabilities	Other non-current liabilities
Total lease liabilities	$ 1,506,169	$ 1,799,487

Leases - Summary of Component_2

Leases - Summary of Components of Lease Cost (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Lessee Lease Description [Line Items]
Total lease costs	$ 186,651	$ 212,154
Cost of Revenue
Lessee Lease Description [Line Items]
Operating lease cost	60,766	60,944
Selling, General and Administrative Expenses
Lessee Lease Description [Line Items]
Operating lease cost	33,026	36,542
Research and Development Expenses
Lessee Lease Description [Line Items]
Operating lease cost	21,310	37,135
Depreciation and Amortization
Lessee Lease Description [Line Items]
Finance lease cost	57,386	67,497
Interest expense, net
Lessee Lease Description [Line Items]
Finance lease cost	$ 14,163	$ 10,036

Leases - Summary of Maturities

Leases - Summary of Maturities of Lease Liabilities (Details)	Sep. 30, 2024 USD ($)
Operating Leases
Remainder of 2025	$ 311,147
2026	354,960
2027	241,622
2028	183,599
2029	56,967
Total lease payments	1,148,295
Less: Interest	(161,251)
Present value of lease liabilities	987,044
Finance Leases
Remainder of 2025	247,175
2026	277,359
2027	44,615
Total lease payments	569,149
Less: Interest	(50,024)
Present value of lease liabilities	$ 519,125

Leases - Summary of Weighted Av

Leases - Summary of Weighted Average Assumptions on Lease Term and Discount Rate and Supplemental Cash Flow Information Related to Leases (Details)	3 Months Ended
	Sep. 30, 2024 USD ($)
Lessee Disclosure [Abstract]
Operating lease remaining lease term	3 years 3 months 18 days
Operating lease discount rate	8.53%
Finance lease remaining lease term	1 year 7 months 6 days
Finance lease discount rate	9.48%
Cash paid for operating leases	$ 114,089
Cash paid for finance leases	$ 105,709

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024
Revenue Recognition [Line Items]
Maximum term of payments for transfer goods and services	1 year
Bad debt expense	$ 0	$ 200,000
Revenue recognized	200,000	400,000
Revenue	8,309,476	10,757,347
Vision Bioenergy
Revenue Recognition [Line Items]
Unbilled receivables	200,000		$ 200,000
ADAMA Collaboration Agreement | Seed Sales
Revenue Recognition [Line Items]
Revenue	$ (100,000)	$ 500,000
Minimum
Revenue Recognition [Line Items]
Term of customer invoice payment	30 days
Maximum
Revenue Recognition [Line Items]
Term of customer invoice payment	180 days

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Disaggregation Of Revenue [Line Items]
Total revenue	$ 8,309,476	$ 10,757,347
Alfalfa
Disaggregation Of Revenue [Line Items]
Total revenue	6,708,003	7,086,370
Sorghum
Disaggregation Of Revenue [Line Items]
Total revenue	1,432,857	3,509,966
Other
Disaggregation Of Revenue [Line Items]
Total revenue	11,224	(46,649)
Services
Disaggregation Of Revenue [Line Items]
Total revenue	$ 157,392	$ 207,660

Revenue Recognition - Schedule

Revenue Recognition - Schedule of Revenues and Percentage of Revenue from External Customers by Country (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 8,309,476	$ 10,757,347
Revenue from external customers by country, percentage	100%	100%
United States
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 2,934,716	$ 3,014,244
Revenue from external customers by country, percentage	35%	28%
Libya
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 1,295,550	$ 1,072,800
Revenue from external customers by country, percentage	16%	10%
Mexico
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 1,052,781	$ 1,562,814
Revenue from external customers by country, percentage	13%	9%
Sudan
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 807,530	$ 1,267,933
Revenue from external customers by country, percentage	10%	12%
South Africa
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 533,125	$ 1,195,553
Revenue from external customers by country, percentage	6%	11%
Egypt
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 496,360	$ 0
Revenue from external customers by country, percentage	6%	0%
Uganda
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 299,640	$ 40,000
Revenue from external customers by country, percentage	4%	0%
Morocco
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 287,994	$ 0
Revenue from external customers by country, percentage	3%	0%
Qatar
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 148,574	$ 58,500
Revenue from external customers by country, percentage	2%	1%
Argentina
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 89,289	$ 35,400
Revenue from external customers by country, percentage	1%	0%
Saudi Arabia
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 0	$ 2,208,738
Revenue from external customers by country, percentage	0%	26%
Other
Disaggregation of Revenue [Line Items]
Revenues from external customers	$ 363,917	$ 301,365
Revenue from external customers by country, percentage	4%	3%

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	$ 41,410,524		$ 41,410,524
Intangible accumulated amortization	(18,392,132)		(17,938,186)
Intangible asset	23,018,392		23,472,338
Intangible amortization expense	(453,946)	$ (500,000)
Intellectual Property
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	33,325,737		33,325,737
Intangible accumulated amortization	(13,406,348)		(13,060,119)
Intangible asset	19,919,389		20,265,618
Intangible amortization expense	(346,229)
Trade Name
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	1,831,928		1,831,928
Intangible accumulated amortization	(1,200,092)		(1,178,972)
Intangible asset	631,836		652,956
Intangible amortization expense	(21,120)
Customer Relationships
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	1,596,653		1,596,653
Intangible accumulated amortization	(1,042,225)		(1,019,623)
Intangible asset	554,428		577,030
Intangible amortization expense	(22,602)
GI Customer list
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	121,786		121,786
Intangible accumulated amortization	(94,922)		(93,131)
Intangible asset	26,864		28,655
Intangible amortization expense	(1,791)
Supply Agreement
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	1,512,667		1,512,667
Intangible accumulated amortization	(907,600)		(888,692)
Intangible asset	605,067		623,975
Intangible amortization expense	(18,908)
Grower Relationships
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	2,343,977		2,343,977
Intangible accumulated amortization	(1,249,560)		(1,223,208)
Intangible asset	1,094,417		1,120,769
Intangible amortization expense	(26,352)
Internal use software
Finite Lived Intangible Assets [Line Items]
Intangible gross carrying amount	677,776		677,776
Intangible accumulated amortization	(491,385)		(474,441)
Intangible asset	186,391		$ 203,335
Intangible amortization expense	$ (16,944)

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 453,946	$ 500,000

Intangible Assets - Intangible

Intangible Assets - Intangible Assets (Future Amortization) (Details)	Sep. 30, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2025	$ 1,343,921
2026	1,714,386
2027	1,663,502
2028	1,606,211
2029	1,586,728
Thereafter	$ 15,103,644

Property, Plant and Equipment -

Property, Plant and Equipment - Components of Property, Plant and Equipment (Details) - USD ($)	Sep. 30, 2024	Jun. 30, 2024
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	$ 12,878,992	$ 12,809,793
Less: accumulated depreciation	(6,898,367)	(6,682,595)
Property, plant and equipment, net	5,980,625	6,127,198
Land and improvements
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	586,849	586,849
Buildings and improvements
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	2,365,835	2,371,565
Machinery and Equipment
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	8,785,882	8,621,280
Vehicles
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	663,778	648,836
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	473,307	552,810
Construction in progress
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	$ 3,341	$ 28,453

Property, Plant and Equipment_2

Property, Plant and Equipment - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 0.3	$ 0.3

Investments - Additional Inform

Investments - Additional Information (Details)	Sep. 30, 2024	Jun. 30, 2024
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Ownership interest	34%	34%

Investments - Summary of Financ

Investments - Summary of Financial Information of Unaudited Balance Sheet (Details) - USD ($)	Sep. 30, 2024	Jun. 30, 2024	Sep. 30, 2023	Jun. 30, 2023
Schedule of Equity Method Investments [Line Items]
Cash	$ 480,359	$ 286,508
Intangible assets	23,018,392	23,472,338
Other assets	1,272,948	1,364,532
TOTAL ASSETS	96,611,154	120,725,541
Current liabilities	54,880,940	69,242,324
Equity	30,521,192	39,262,360	$ 62,828,906	$ 68,823,433
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	96,611,154	120,725,541
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Cash	4,523,734	6,327,459
Other current assets	6,689,246	3,138,627
Fixed assets	17,818,133	17,866,091
Intangible assets	18,976,035	19,624,187
Goodwill	11,564,157	11,564,157
Other assets	155,214	235,613
TOTAL ASSETS	59,726,519	58,756,134
Current liabilities	4,957,388	1,485,283
Long-term liabilities	77,845	133,070
Equity	54,691,286	57,137,781
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY	$ 59,726,519	$ 58,756,134

Investments - Summary of Fina_2

Investments - Summary of Financial Information of Unaudited Income Statement (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Schedule of Equity Method Investments [Line Items]
Revenue	$ 8,309,476	$ 10,757,347
Loss from operations	(4,233,578)	(2,992,044)
Net loss	(16,229,726)	(5,949,629)
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Revenue	307,772	110,900
Gross loss	(486,271)	(549,607)
Loss from operations	(2,497,925)	(2,432,762)
Net loss	$ (2,446,495)	$ (2,362,135)

Investments - Schedule of Carry

Investments - Schedule of Carrying Amount of The Company's Equity Method Investments (Details) - USD ($)	Sep. 30, 2024	Jun. 30, 2024
Schedule of Equity Method Investments [Line Items]
Total equity method investments, Carrying Amount	$ 18,847,331	$ 19,694,209
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Total equity method investments, Carrying Amount	$ 18,847,331	$ 19,694,209
Economic Interest	34%	34%

Investments - Schedule of Compa

Investments - Schedule of Company's Equity Method Investments (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Schedule of Equity Method Investments [Line Items]
Beginning balance	$ 19,694,209
Equity in loss of equity method investment	(846,878)	$ (776,973)
Ending balance	18,847,331
Vision Bioenergy
Schedule of Equity Method Investments [Line Items]
Beginning balance	19,694,209
Equity in loss of equity method investment	(846,878)
Ending balance	$ 18,847,331

Debt - Schedule of Total Debt O

Debt - Schedule of Total Debt Outstanding (Details) - USD ($)	Sep. 30, 2024	Jun. 30, 2024
Current portion of working capital lines of credit
Total current portion of working capital lines of credit, net	$ 16,114,500	$ 16,174,537
Total working capital lines of credit, net	16,114,500	16,174,537
Current portion of long-term debt
Finance leases, Current	$ 295,671	$ 314,980
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Total current portion, net	Total current portion, net
Debt issuance costs, Current	$ (106,528)	$ (106,528)
Total current portion, net	284,239	315,304
Long-term debt, less current portion
Finance leases, Noncurrent	$ 223,454	$ 303,395
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Long-Term Debt and Lease Obligation	Long-Term Debt and Lease Obligation
Debt issuance costs, Noncurrent	$ (76,759)	$ (103,609)
Total long-term portion, net	4,652,369	4,721,849
Total debt, net	4,936,608	5,037,153
CIBC
Current portion of working capital lines of credit
Total current portion of working capital lines of credit, net	16,169,873	16,279,194
CIBC and NAB
Current portion of long-term debt
Debt issuance costs, Current	(55,373)	(104,657)
Vehicle Loans | Ford Credit
Current portion of long-term debt
Secured Debt, Current	95,096	106,852
Long-term debt, less current portion
Secured Long-term Debt, Noncurrent	205,674	222,063
AgAmerica RE Long
Long-term debt, less current portion
Secured Long-term Debt, Noncurrent	$ 4,300,000	$ 4,300,000

Debt - CIBC Credit Facility - A

Debt - CIBC Credit Facility - Additional Information (Details) - USD ($)							3 Months Ended
	Oct. 31, 2024	Sep. 18, 2024	Jul. 03, 2024	Jul. 01, 2024	Mar. 22, 2023	Dec. 26, 2019	Sep. 30, 2024	Oct. 01, 2024
Line Of Credit Facility [Line Items]
Line of credit facility, remaining borrowing capacity							$ 0
Subsequent Event
Line Of Credit Facility [Line Items]
Debt instrument, maturity date	Dec. 31, 2024
CIBC
Line Of Credit Facility [Line Items]
Line of credit and security agreement date						Dec. 26, 2019
Line of credit facility, maximum borrowing capacity						$ 35,000,000
Debt instrument, maturity date			Oct. 31, 2024		Aug. 31, 2024
Increased applicable interest rate margin on advances		2%
Loan agreement fees			$ 15,000	$ 10,000
Line of credit facility, borrowing capacity, description							Availability of funds under the Amended CIBC Credit Facility is subject to a borrowing base equal to (a) up to 85% of eligible domestic accounts receivable, plus (b) up to 90% of eligible foreign accounts receivable, plus (c) up to the lesser of (i) 65% of eligible inventory and (ii) 85% of the appraised net orderly liquidation value of eligible inventory
Debt instrument, debt default, Increase in interest rate per annum							2%
CIBC | From July 1, 2024 through August 31, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit			5,000,000
CIBC | From July 1, 2024 through July 14, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit			8,500,000
CIBC | From July 15, 2024 through August 14, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit			7,500,000
CIBC | From August 15, 2024 through September 15, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit			7,000,000
CIBC | From September 16, 2024 through September 29, 2024
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit			6,500,000
CIBC | From September 30, 2024 through the Maturity Date
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit			5,000,000
CIBC | Line of Credit
Line Of Credit Facility [Line Items]
Debt instrument, interest rate							10.50%
CIBC | Line of Credit | Federal Funds Rate
Line Of Credit Facility [Line Items]
Basis spread on variable rate							0.50%
CIBC | Line of Credit | Prime Rate
Line Of Credit Facility [Line Items]
Basis spread on variable rate							2.50%
CIBC | Line of Credit | From July 1, 2024 through July 31, 2024
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			20,000,000
CIBC | Line of Credit | From August 1, 2024 through September 1, 2024
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			18,500,000
CIBC | Line of Credit | From September 2, 2024 through September 15, 2024
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			17,500,000
CIBC | Line of Credit | From September 16, 2024 through October 9, 2024
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			15,000,000
CIBC | Line of Credit | From October 10, 2024 through Maturity Date
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			$ 13,000,000
CIBC | Minimum
Line Of Credit Facility [Line Items]
Borrowing base value of an eligible inventory sublimit				$ 5,000,000
CIBC | Maximum
Line Of Credit Facility [Line Items]
Borrowing base in percentage based on eligible domestic accounts receivable							85%
Borrowing base in percentage based on eligible foreign accounts receivable							90%
Borrowing base in percentage based on eligible inventory							65%
Borrowing base in percentage based on liquidation value of the inventory, subject to lender reserves							85%
CIBC | Subsequent Event
Line Of Credit Facility [Line Items]
Debt instrument, maturity date	Nov. 30, 2024
Loan agreement fees	$ 25,000
CIBC | Subsequent Event | Line of Credit
Line Of Credit Facility [Line Items]
Loan agreement fees								$ 25,000

Debt - AgAmerica Note - Additio

Debt - AgAmerica Note - Additional Information (Details) - Secured Real Estate Note - AgAmerica $ in Millions	Jun. 20, 2023 USD ($) Acres	Sep. 30, 2024
Line of Credit Facility [Line Items]
Debt face amount | $	$ 4.3
Number of acres of land held as security | Acres	31
Basis spread on variable rate	4.85%
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]	Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Debt instrument, annual interest rate		9.81%

Debt - MFP Loan Agreement - Add

Debt - MFP Loan Agreement - Additional Information (Details) - USD ($)	Oct. 31, 2024	Jul. 16, 2024	Mar. 22, 2023	Sep. 30, 2024	Jun. 30, 2024	Sep. 22, 2022
Line of Credit Facility [Line Items]
Facility outstanding amount				$ 16,114,500	$ 16,174,537
Standby Letters of Credit
Line of Credit Facility [Line Items]
Debt instrument, maturity date		Nov. 30, 2024	Sep. 30, 2024
Line of credit facility, maximum borrowing capacity			$ 13,000,000
Debt face amount						$ 9,000,000
Subsequent Event
Line of Credit Facility [Line Items]
Debt instrument, maturity date	Dec. 31, 2024
Subsequent Event | Standby Letters of Credit
Line of Credit Facility [Line Items]
Debt instrument, maturity date	Dec. 31, 2024
MFP Loan Agreement
Line of Credit Facility [Line Items]
Debt instrument, maturity date		May 31, 2025
Line of credit facility, maximum borrowing capacity						$ 9,000,000
Line of credit facility, unused capacity commitment fee percentage		4.25%
Debt instrument, percentage of interest payable in cash		50%
Debt instrument, percentage of interest paid in kind		50%
Facility outstanding amount				$ 0
MFP Loan Agreement | Reference Rate Floor
Line of Credit Facility [Line Items]
Debt instrument, interest rate		1.25%
MFP Loan Agreement | SOFR
Line of Credit Facility [Line Items]
Basis spread on variable rate		9.25%

Debt - Schedule of Annual Matur

Debt - Schedule of Annual Maturities of Long-Term Debt Excluding Finance Lease Liabilites (Details)	Sep. 30, 2024 USD ($)
Debt Disclosure [Abstract]
Remainder of 2025	$ 95,096
2026	4,395,096
2027	95,096
2028	15,482
Total	$ 4,600,770

Business Segments - Additional

Business Segments - Additional Information (Details)	3 Months Ended
	Sep. 30, 2024 Segment
Segment Reporting [Abstract]
Number of operating segments	2

Business Segments - Summary of

Business Segments - Summary of Business Activity by Segment (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Revenue
Revenue	$ 8,309,476	$ 10,757,347
Gross profit (excluding depreciation and amortization)
Gross profit (excluding depreciation and amortization)	1,336,368	2,725,150
Americas
Revenue
Revenue	4,132,935	4,854,052
Gross profit (excluding depreciation and amortization)
Gross profit (excluding depreciation and amortization)	728,263	952,325
International
Revenue
Revenue	4,089,006	5,903,295
Gross profit (excluding depreciation and amortization)
Gross profit (excluding depreciation and amortization)	797,183	1,773,768
Other
Revenue
Revenue	87,535	0
Gross profit (excluding depreciation and amortization)
Gross profit (excluding depreciation and amortization)	$ (189,078)	$ (943)

Equity - Additional Information

Equity - Additional Information (Details) - MFP Loan Agreement - USD ($) $ / shares in Units, $ in Millions		3 Months Ended
	Mar. 22, 2023	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2024
Class Of Stock [Line Items]
Warrants to purchase of common stock				138,600
Warrant expiration term	5 years
Interest expense amortized		$ 0.2	$ 0.2
Minimum
Class Of Stock [Line Items]
Warrant exercise price per share		$ 30.4
Maximum
Class Of Stock [Line Items]
Warrant exercise price per share		$ 40.85

Equity-Based Compensation - Add

Equity-Based Compensation - Additional Information (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation	$ 243,908	$ 411,820
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options granted	0	0
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation, total compensation cost not yet recognized, period for recognition	1 year 1 month 6 days
Number of restricted stock units issued	5,246	1,361
Fair value of awards granted	$ 35,375	$ 29,373
Unrecognized stock compensation expense related to restricted stock units	$ 278,144
Maximum | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	3 years
Minimum | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	1 year
2019 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for issuance of grants	8,676
2009 and 2019 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock compensation expense, net of estimated forfeitures, related to options	$ 209,592
Stock-based compensation, total compensation cost not yet recognized, period for recognition	1 year 8 months 12 days

Equity-Based Compensation - Sum

Equity-Based Compensation - Summary Of Stock Option Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Options, Outstanding as of beginning of period	279,670
Options, Granted	0
Options, Exercised	0
Options, Canceled/forfeited/expired	0
Options, Outstanding as of end of period	279,670	279,670
Options, vested and exercisable at end of period	241,434
Options, vested and expected to vest	279,422
Weighted-Average Exercise Prices, Outstanding as of beginning of period	$ 39.14
Weighted-Average Exercise Prices, Granted	0
Weighted-Average Exercise Prices, Exercised	0
Weighted-Average Exercise Prices, Canceled/forfeited/expired	0
Weighted-Average Exercise Prices, Outstanding as of end of period	39.14	$ 39.14
Weighted-Average Exercise Prices, vested and exercisable	42.67
Weighted-Average Exercise Price, vested and expected to vest	$ 39.2
Options Outstanding, Weighted-Average Remaining Contractual Term (in years)	6 years 6 months	6 years 9 months 18 days
Weighted-Average Remaining Contractual Term (in years), vested and exercisable	6 years 2 months 12 days
Weighted-Average Remaining Contractual Term (in years), vested and expected to vest	6 years 6 months
Options, Outstanding, Aggregate Intrinsic Value	$ 0
Options, vested and exercisable, Aggregate Intrinsic Value	0
Options, vested and expected to vest, Aggregate Intrinsic Value	$ 0

Equity-Based Compensation - S_2

Equity-Based Compensation - Summary of Activity Related to Non-Vested Restricted Stock Units (Details) - Restricted Stock Units - $ / shares	3 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Nonvested Restricted Stock Units Outstanding, Beginning	64,595
Number of Nonvested Restricted Stock Units, Granted	5,246	1,361
Number of Nonvested Restricted Stock Units, Vested	(1,881)
Number of Nonvested Restricted Stock Units Outstanding, Ending	67,960		64,595
Weighted-Average Grant Date Fair Value, Beginning	$ 11.40
Weighted-Average Grant Date Fair Value, Granted	11.34
Weighted-Average Grant Date Fair Value, Vested	17.04
Weighted-Average Grant Date Fair Value, Ending	$ 10.83		$ 11.40
Weighted-Average Remaining Vesting Period (Years)	1 year 1 month 20 days		1 year 2 months 12 days
Weighted-Average Remaining Vesting Period (Years), Granted	3 months 18 days

Series B Redeemable Convertib_3

Series B Redeemable Convertible Preferred Stock - Additional Information (Details)	3 Months Ended
	Sep. 30, 2024 shares
MEZZANINE EQUITY
Temporary Equity [Line Items]
Issuances and conversion of preferred stock to common stock	0

Series B Redeemable Convertib_4

Series B Redeemable Convertible Preferred Stock - Summary of Changes to Series B Convertible Preferred Stock (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Temporary Equity Disclosure [Abstract]
Mezzanine Equity Beginning Balance, amount	$ 5,768,765
Dividends accrued	102,054	$ 94,207
Accretion of discount for warrants	25,838	$ 25,838
Mezzanine Equity Ending Balance, amount	$ 5,896,657

Non-Cash Activities for State_3

Non-Cash Activities for Statements of Cash Flows - Schedule of Condensed Consolidated Statements of Cash Flows for Non-Cash Activities (Details) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Non-cash investing activities:
ROU assets financed by lease liabilities and lease modifications and reassessments	$ (106,838)	$ 487,611
Non-cash financing activities:
Dividends accrued for participating securities	102,054	94,207
Accretion of discount for series B preferred stock warrants	$ 25,838	$ 25,838

Subsequent Events - Additional

Subsequent Events - Additional Information (Details)	Oct. 31, 2024 USD ($)	Oct. 17, 2024	Oct. 04, 2024	Sep. 26, 2024	Jul. 16, 2024	Jul. 03, 2024 USD ($)	Mar. 22, 2023	Nov. 22, 2024 USD ($)	Jul. 24, 2024 USD ($)	Jul. 01, 2024 USD ($)	Jun. 30, 2024 USD ($)
Discontinued Operations | S&W Seed Company Australia Pty Ltd
Subsequent Event [Line Items]
Inventory transferred									$ 15,274,546		$ 15,478,760
Minimum | Common Stock
Subsequent Event [Line Items]
Reverse stock split ratio				0.2
Maximum | Common Stock
Subsequent Event [Line Items]
Reverse stock split ratio				0.05
Standby Letters of Credit
Subsequent Event [Line Items]
Debt instrument, maturity date					Nov. 30, 2024		Sep. 30, 2024
CIBC
Subsequent Event [Line Items]
Debt instrument, maturity date						Oct. 31, 2024	Aug. 31, 2024
Loan agreement fees						$ 15,000				$ 10,000
Subsequent Event
Subsequent Event [Line Items]
Debt instrument, maturity date	Dec. 31, 2024
Reverse stock split term			The terms of the Reverse Stock Split are such that every 19 shares of the Company’s issued and outstanding common stock were automatically combined into one issued and outstanding share of common stock, without any change in par value per share.
Subsequent Event | Discontinued Operations | S&W Seed Company Australia Pty Ltd
Subsequent Event [Line Items]
Inventory transferred								$ 6,000,000
Subsequent Event | Common Stock
Subsequent Event [Line Items]
Reverse stock split ratio		0.053	0.053
Subsequent Event | Standby Letters of Credit
Subsequent Event [Line Items]
Debt instrument, maturity date	Dec. 31, 2024
Subsequent Event | CIBC
Subsequent Event [Line Items]
Debt instrument, maturity date	Nov. 30, 2024
Loan agreement fees	$ 25,000